<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN" "JATS-archivearticle1.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="review-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD Journal Publishing DTD v2.3 20070202//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName journalpublishing.dtd?><?SourceDTD.Version 2.3?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">Front Immunol</journal-id><journal-id journal-id-type="iso-abbrev">Front Immunol</journal-id><journal-id journal-id-type="publisher-id">Front. Immunol.</journal-id><journal-title-group><journal-title>Frontiers in Immunology</journal-title></journal-title-group><issn pub-type="epub">1664-3224</issn><publisher><publisher-name>Frontiers Media S.A.</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">5712212</article-id><article-id pub-id-type="doi">10.3389/fimmu.2017.01643</article-id><article-categories><subj-group subj-group-type="heading"><subject>Immunology</subject><subj-group><subject>Review</subject></subj-group></subj-group></article-categories><title-group><article-title>Functional Impairment of Mononuclear Phagocyte System by the Human Respiratory Syncytial Virus</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Bohmwald</surname><given-names>Karen</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><uri xlink:type="simple" xlink:href="http://frontiersin.org/people/u/229758"/></contrib><contrib contrib-type="author"><name><surname>Espinoza</surname><given-names>Janyra A.</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><uri xlink:type="simple" xlink:href="http://frontiersin.org/people/u/230026"/></contrib><contrib contrib-type="author"><name><surname>Pulgar</surname><given-names>Ra&#x000fa;l A.</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><uri xlink:type="simple" xlink:href="http://frontiersin.org/people/u/458867"/></contrib><contrib contrib-type="author"><name><surname>Jara</surname><given-names>Evelyn L.</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><uri xlink:type="simple" xlink:href="http://frontiersin.org/people/u/230052"/></contrib><contrib contrib-type="author"><name><surname>Kalergis</surname><given-names>Alexis M.</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><xref ref-type="corresp" rid="cor1">*</xref><uri xlink:type="simple" xlink:href="http://frontiersin.org/people/u/217683"/></contrib></contrib-group><aff id="aff1"><sup>1</sup><institution>Millennium Institute on Immunology and Immunotherapy, Departamento de Gen&#x000e9;tica Molecular y Microbiolog&#x000ed;a, Facultad de Ciencias Biol&#x000f3;gicas, Pontificia Universidad Cat&#x000f3;lica de Chile</institution>, <addr-line>Santiago</addr-line>, <country>Chile</country></aff><aff id="aff2"><sup>2</sup><institution>Departamento de Endocrinolog&#x000ed;a, Facultad de Medicina, Escuela de Medicina, Pontificia Universidad Cat&#x000f3;lica de Chile</institution>, <addr-line>Santiago</addr-line>, <country>Chile</country></aff><author-notes><fn fn-type="edited-by"><p>Edited by: Luciana Balboa, Consejo Nacional de Investigaciones Cient&#x000ed;ficas y T&#x000e9;cnicas (CONICET), Argentina</p></fn><fn fn-type="edited-by"><p>Reviewed by: Robert Braidwood Sim, University of Leicester, United Kingdom; Silvia Beatriz Boscardin, University of S&#x000e3;o Paulo, Brazil</p></fn><corresp content-type="corresp" id="cor1">*Correspondence: Alexis M. Kalergis, <email>akalergis@bio.puc.cl</email></corresp><fn fn-type="other" id="fn001"><p>Specialty section: This article was submitted to Microbial Immunology, a section of the journal Frontiers in Immunology</p></fn></author-notes><pub-date pub-type="epub"><day>27</day><month>11</month><year>2017</year></pub-date><pub-date pub-type="collection"><year>2017</year></pub-date><volume>8</volume><elocation-id>1643</elocation-id><history><date date-type="received"><day>14</day><month>8</month><year>2017</year></date><date date-type="accepted"><day>10</day><month>11</month><year>2017</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2017 Bohmwald, Espinoza, Pulgar, Jara and Kalergis.</copyright-statement><copyright-year>2017</copyright-year><copyright-holder>Bohmwald, Espinoza, Pulgar, Jara and Kalergis</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p></license></permissions><abstract><p>The mononuclear phagocyte system (MPS) comprises of monocytes, macrophages (M&#x003a6;), and dendritic cells (DCs). MPS is part of the first line of immune defense against a wide range of pathogens, including viruses, such as the human respiratory syncytial virus (hRSV). The hRSV is an enveloped virus that belongs to the <italic>Pneumoviridae</italic> family, <italic>Orthopneumovirus</italic> genus. This virus is the main etiological agent causing severe acute lower respiratory tract infection, especially in infants, children and the elderly. Human RSV can cause bronchiolitis and pneumonia and it has also been implicated in the development of recurrent wheezing and asthma. Monocytes, M&#x003a6;, and DCs significantly contribute to acute inflammation during hRSV-induced bronchiolitis and asthma exacerbation. Furthermore, these cells seem to be an important component for the association between hRSV and reactive airway disease. After hRSV infection, the first cells encountered by the virus are respiratory epithelial cells, alveolar macrophages (AMs), DCs, and monocytes in the airways. Because AMs constitute the predominant cell population at the alveolar space in healthy subjects, these cells work as major innate sentinels for the recognition of pathogens. Although adaptive immunity is crucial for viral clearance, AMs are required for the early immune response against hRSV, promoting viral clearance and controlling immunopathology. Furthermore, exposure to hRSV may affect the phagocytic and microbicidal capacity of monocytes and M&#x003a6;s against other infectious agents. Finally, different studies have addressed the roles of different DC subsets during infection by hRSV. In this review article, we discuss the role of the lung MPS during hRSV infection and their involvement in the development of bronchiolitis.</p></abstract><kwd-group><kwd>human respiratory syncytial virus</kwd><kwd>dendritic cells</kwd><kwd>macrophages</kwd><kwd>infection</kwd><kwd>immunity</kwd></kwd-group><funding-group><award-group><funding-source id="cn01">Comisi&#x000f3;n Nacional de Investigaci&#x000f3;n Cient&#x000ed;fica y Tecnol&#x000f3;gica<named-content content-type="fundref-id">10.13039/501100002848</named-content></funding-source><award-id rid="cn01">FONDECYT 1070352, CONICYT/FONDECYT POSTDOCTORADO 3150559</award-id></award-group></funding-group><counts><fig-count count="3"/><table-count count="1"/><equation-count count="0"/><ref-count count="126"/><page-count count="12"/><word-count count="9668"/></counts></article-meta></front><body><sec sec-type="introduction" id="S1"><title>Introduction</title><sec id="S1-1"><title>Mononuclear Phagocyte System (MPS): Background</title><p>Since the 1960s, the term MPS was defined as a family of cells differentiated from a common committed progenitor derived from the bone marrow (<xref rid="B1" ref-type="bibr">1</xref>&#x02013;<xref rid="B3" ref-type="bibr">3</xref>). The MPS is composed of three major cell types, including monocytes, macrophages (M&#x003a6;s), and dendritic cells (DCs) (<xref rid="B2" ref-type="bibr">2</xref>, <xref rid="B4" ref-type="bibr">4</xref>). These cells share common morphologic and functional features, such as stellated form and the endocytic capacity (<xref rid="B2" ref-type="bibr">2</xref>). In addition, MPS cells express a heterogeneity of cell surface markers based on the tissue where they are located (<xref rid="B3" ref-type="bibr">3</xref>, <xref rid="B5" ref-type="bibr">5</xref>, <xref rid="B6" ref-type="bibr">6</xref>).</p><p>In the lungs, the cells of the MPS play a key role during host defense and homeostasis (<xref rid="B7" ref-type="bibr">7</xref>, <xref rid="B8" ref-type="bibr">8</xref>). M&#x003a6;s are found mostly in the alveolus adjacent to the epithelium and less frequently in the terminal airways and interstitial space, while most DCs are located in the pulmonary interstitium (<xref rid="B7" ref-type="bibr">7</xref>). Finally, this cellular system play critical roles in pulmonary host defense against viral pathogens, such as human respiratory syncytial virus (hRSV), which will be discussed in detail below.</p><sec id="S1-1-1"><title>Monocytes</title><p>Monocytes originate in the bone marrow from a common myeloid progenitor that is shared with granulocytes and macrophages (<xref rid="B9" ref-type="bibr">9</xref>). Furthermore, recruitment of monocytes is critical for an effective control and clearance of viral infections (<xref rid="B10" ref-type="bibr">10</xref>). It has been described that, in the bone marrow, the earliest monocytic precursor needs between two or three generations before becoming a mature monocyte that can be released into the peripheral blood. Once in the blood, these cells circulate for several days before entering the tissues and replenishing tissue macrophage populations (<xref rid="B10" ref-type="bibr">10</xref>). In the absence of an inflammatory process, it is thought that migration of monocytes into tissues is a random phenomenon (<xref rid="B10" ref-type="bibr">10</xref>). Once there, monocytes are able to differentiate into tissue-specific-resident phagocytes (<xref rid="B8" ref-type="bibr">8</xref>, <xref rid="B10" ref-type="bibr">10</xref>). Monocytes can differentiate <italic>in vivo</italic> and <italic>in vitro</italic> into other myeloid cells, such as M&#x003a6;s or DCs in response to cytokines including granulocyte-macrophage colony-stimulating factor and macrophage colony-stimulating factor (<xref rid="B11" ref-type="bibr">11</xref>&#x02013;<xref rid="B13" ref-type="bibr">13</xref>).</p><p>In humans, monocytes can be classified into three groups according to molecular markers and their function: (1) classical (CD14<sup>++</sup>CD16<sup>&#x02212;</sup>); (2) intermediate (CD14<sup>++</sup>CD16<sup>+</sup>); and (3) non-classical (CD14<sup>+</sup>CD16<sup>+</sup>) (<xref rid="B12" ref-type="bibr">12</xref>, <xref rid="B14" ref-type="bibr">14</xref>). While classical monocytes exert a high myeloperoxidase and intermediate phagocytic activity, non-classical monocytes are important during inflammatory and antiviral responses (<xref rid="B12" ref-type="bibr">12</xref>, <xref rid="B15" ref-type="bibr">15</xref>). On the other hand, murine monocytes are classified into two groups: (1) LyC6<sup>low</sup> and (2) LyC6<sup>High</sup> (<xref rid="B12" ref-type="bibr">12</xref>). While the LyC6<sup>High</sup> subpopulation is responsible for the inflammatory and antimicrobial response (<xref rid="B11" ref-type="bibr">11</xref>, <xref rid="B12" ref-type="bibr">12</xref>), LyC6<sup>low</sup> monocytes contribute mainly to immune surveillance and to tissue repair (<xref rid="B12" ref-type="bibr">12</xref>).</p></sec><sec id="S1-1-2"><title>Macrophages (M&#x003a6;s)</title><p>Macrophages are characterized by their phagocytic capacity, which is required for the removal of cellular debris during tissue repair processes (<xref rid="B16" ref-type="bibr">16</xref>). M&#x003a6;s are present in different tissues, such as the brain, bone marrow, lung, and liver, among others. During an inflammatory response, M&#x003a6;s can migrate into various tissues from the peripheral blood (<xref rid="B16" ref-type="bibr">16</xref>).</p><p>Macrophages can be activated both by a microbial infection or by endogenous stimuli, which include inflammatory cytokines, such as IFN-&#x003b3;, IL-4, and IL-13 (<xref rid="B16" ref-type="bibr">16</xref>). These cells can display two different activation profiles known as M1 (classic) and M2 (alternative) (<xref rid="B17" ref-type="bibr">17</xref>). The M1 M&#x003a6; subset displays higher antimicrobial, inflammatory and antigen-presenting capacity (<xref rid="B17" ref-type="bibr">17</xref>). Meanwhile, the M2 M&#x003a6; subset mainly displays anti-inflammatory activity (<xref rid="B16" ref-type="bibr">16</xref>&#x02013;<xref rid="B18" ref-type="bibr">18</xref>). In addition, M1 M&#x003a6;s are stimulated by IFN-&#x003b3;, while the activation of M2 M&#x003a6;s requires IL-4 and IL-13 (<xref rid="B17" ref-type="bibr">17</xref>, <xref rid="B19" ref-type="bibr">19</xref>). Importantly, M1 and M2 polarization can be modulated by viral infections (<xref rid="B20" ref-type="bibr">20</xref>). The role of these cells during hRSV infection will be discussed below.</p></sec><sec id="S1-1-3"><title>Dendritic Cells</title><p>Dendritic cells are specialized cells whose main function is to modulate the communication between the innate and acquired immune responses (<xref rid="B21" ref-type="bibr">21</xref>). These cells are considered as professional antigen-presenting cells (APCs) with a low phagocytic capacity, as compared to other cells of the MPS (<xref rid="B7" ref-type="bibr">7</xref>). In mice, two major subsets of DCs have been identified: (1) conventional DCs (cDCs) or &#x0201c;myeloid&#x0201d; DCs and (2) plasmacytoid DCs (pDCs) (Table <xref ref-type="table" rid="T1">1</xref>). While cDCs locate mainly in lymphoid and non-lymphoid tissues, pDCs can be found in blood, lymph nodes (LN), and lymphoid tissues (<xref rid="B22" ref-type="bibr">22</xref>). Additionally, murine cDCs can be divided in two subtypes: CD103<sup>+</sup> cDCs and CD11b<sup>+</sup> cDCs (Table <xref ref-type="table" rid="T1">1</xref>) (<xref rid="B22" ref-type="bibr">22</xref>, <xref rid="B23" ref-type="bibr">23</xref>). Further, cDCs can be separated in lymphoid tissues in two subsets: CD8<sup>+</sup> and CD11b<sup>+</sup> cDCs. CD8<sup>+</sup> cDCs express the CD8&#x003b1; transcript and protein, but not CD8&#x003b1;&#x003b2; heterodimer, which is most commonly expressed by CD8<sup>+</sup> T cells (Table <xref ref-type="table" rid="T1">1</xref>) (<xref rid="B22" ref-type="bibr">22</xref>).</p><table-wrap id="T1" position="float"><label>Table 1</label><caption><p>Dendritic cell (DC) subsets, location, and their surface markers.</p></caption><table frame="hsides" rules="groups"><thead><tr><th valign="top" align="left" rowspan="1" colspan="1">DC subset</th><th valign="top" align="left" rowspan="1" colspan="1">Location</th><th valign="top" align="left" rowspan="1" colspan="1">Surface markers</th><th valign="top" align="center" rowspan="1" colspan="1">Reference</th></tr></thead><tbody><tr><td align="left" valign="top" rowspan="5" colspan="1">Mouse conventional DC (cDC) CD103<sup>+</sup></td><td align="left" valign="top" rowspan="5" colspan="1">Lymphoid organs and non-lymphoid organs</td><td align="left" valign="top" rowspan="1" colspan="1">CD11c<sup>+</sup></td><td align="center" valign="top" rowspan="5" colspan="1">(<xref rid="B22" ref-type="bibr">22</xref>)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">MHC-II<sup>+</sup></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">F4/80<sup>&#x02212;</sup></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">CD11b<sup>&#x02212;</sup></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">CD103<sup>+</sup></td></tr><tr><td valign="top" align="left" colspan="4" rowspan="1"><hr/></td></tr><tr><td align="left" valign="top" rowspan="6" colspan="1">Mouse cDC CD11b<sup>+</sup></td><td align="left" valign="top" rowspan="6" colspan="1">Lymphoid organs</td><td align="left" valign="top" rowspan="1" colspan="1">CD11c<sup>+</sup></td><td align="center" valign="top" rowspan="6" colspan="1">(<xref rid="B22" ref-type="bibr">22</xref>)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">MHC-II<sup>+&#x02212;</sup></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">CD103<sup>&#x02212;</sup></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">F4/80<sup>&#x02212;</sup> integrin</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x003b1;E&#x003b2;7<sup>+</sup></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">CD11b<sup>+</sup></td></tr><tr><td valign="top" align="left" colspan="4" rowspan="1"><hr/></td></tr><tr><td align="left" valign="top" rowspan="5" colspan="1">Mouse cDC CD8&#x003b1;<sup>+</sup></td><td align="left" valign="top" rowspan="5" colspan="1">Lymphoid organs</td><td align="left" valign="top" rowspan="1" colspan="1">CD11c<sup>+</sup></td><td align="center" valign="top" rowspan="5" colspan="1">(<xref rid="B22" ref-type="bibr">22</xref>, <xref rid="B24" ref-type="bibr">24</xref>)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">CD205<sup>+</sup></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">MHC-II<sup>+</sup></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">CD11b<sup>&#x02212;</sup></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">CD8&#x003b1;<sup>+</sup></td></tr><tr><td valign="top" align="left" colspan="4" rowspan="1"><hr/></td></tr><tr><td align="left" valign="top" rowspan="6" colspan="1">Human myeloid DC CD1c<sup>+</sup></td><td align="left" valign="top" rowspan="6" colspan="1">Lymphoid organs</td><td align="left" valign="top" rowspan="1" colspan="1">CD1c<sup>+</sup></td><td align="center" valign="top" rowspan="6" colspan="1">(<xref rid="B14" ref-type="bibr">14</xref>, <xref rid="B25" ref-type="bibr">25</xref>, <xref rid="B26" ref-type="bibr">26</xref>)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">CD11b<sup>+</sup></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">CD11c<sup>high</sup></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">BDCA-1<sup>+</sup></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">CD206<sup>+</sup></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">CD207<sup>+</sup></td></tr><tr><td valign="top" align="left" colspan="4" rowspan="1"><hr/></td></tr><tr><td align="left" valign="top" rowspan="7" colspan="1">Human myeloid DC CD141<sup>+</sup></td><td align="left" valign="top" rowspan="7" colspan="1">Lymphoid organs</td><td align="left" valign="top" rowspan="1" colspan="1">CD141<sup>+</sup></td><td align="center" valign="top" rowspan="7" colspan="1">(<xref rid="B14" ref-type="bibr">14</xref>, <xref rid="B25" ref-type="bibr">25</xref>, <xref rid="B26" ref-type="bibr">26</xref>)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">CD11c<sup>+</sup></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">CD11b<sup>&#x02212;</sup></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">BDCA-3<sup>+</sup></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">CLEC9A<sup>+</sup></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">XCR1<sup>+</sup></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">CD123<sup>+</sup></td></tr><tr><td valign="top" align="left" colspan="4" rowspan="1"><hr/></td></tr><tr><td align="left" valign="top" rowspan="2" colspan="1">Plasmacytoid DC (pDC)</td><td align="left" valign="top" rowspan="2" colspan="1">Blood, lymph nodes, and lymphoid tissues</td><td align="left" valign="top" rowspan="1" colspan="1">CD11c<sup>low</sup></td><td align="center" valign="top" rowspan="2" colspan="1">(<xref rid="B22" ref-type="bibr">22</xref>)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">mPDCA-1<sup>+</sup></td></tr><tr><td valign="top" align="left" colspan="4" rowspan="1"><hr/></td></tr><tr><td align="left" valign="top" rowspan="6" colspan="1">Human pDC</td><td align="left" valign="top" rowspan="6" colspan="1">Blood and bone marrow</td><td align="left" valign="top" rowspan="1" colspan="1">Lin<sup>&#x02212;</sup></td><td align="center" valign="top" rowspan="6" colspan="1">(<xref rid="B14" ref-type="bibr">14</xref>, <xref rid="B25" ref-type="bibr">25</xref>, <xref rid="B26" ref-type="bibr">26</xref>)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">MHC-II<sup>+</sup></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">CD123<sup>+</sup></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">CD4<sup>+</sup></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">CD303<sup>+</sup></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">CD304<sup>+</sup></td></tr></tbody></table></table-wrap><p>As for the case of human DCs, these cells can be divided into pDCs and myeloid DCs. These latter cells are additionally classified into two subsets: CD1c<sup>+</sup> and CD141<sup>+</sup> (Table <xref ref-type="table" rid="T1">1</xref>) (<xref rid="B14" ref-type="bibr">14</xref>, <xref rid="B26" ref-type="bibr">26</xref>). Here, CD1c<sup>+</sup> and CD141<sup>+</sup> are analogous to the mouse tissue-resident CD11b<sup>+</sup> and CD103<sup>+</sup> DCs, respectively (<xref rid="B27" ref-type="bibr">27</xref>).</p><p>With respect to the function of the various DCs subsets, cDCs display an increased ability of sensing tissue damage independent of their role in the capture, processing, and presentation of antigens (<xref rid="B22" ref-type="bibr">22</xref>). Equivalent to other MPS members, DCs are found in the lungs as is the case for CD103<sup>+</sup> cDCs, CD11b<sup>+</sup> cDCs, and pDCs subsets, which are distributed in the lamina propria (<xref rid="B28" ref-type="bibr">28</xref>). Furthermore, both subsets of cDCs (CD103<sup>+</sup> and CD11b<sup>+</sup>) are found in the alveoli, allowing their migration to the mediastinal LNs (<xref rid="B28" ref-type="bibr">28</xref>). Consistent with this notion, it is known that lung DCs play an active role in the pulmonary pathogenesis caused by viral infection and asthma (<xref rid="B28" ref-type="bibr">28</xref>).</p><p>On the other hand, pDCs are able to secrete large amounts of type I IFN during viral infections and contribute to the maintenance of immune tolerance (<xref rid="B22" ref-type="bibr">22</xref>). The latter activity of pDCs is achieved through the expression of molecules, such as the inducible tolerogenic enzyme indoleamine 2,3-dioxygenase (IDO), the inducible costimulator ligand, and/or the programmed death 1 ligand. These molecules promote the expansion of regulatory T cell (Treg) and the suppression of self-specific and alloreactive lymphocytes (<xref rid="B28" ref-type="bibr">28</xref>&#x02013;<xref rid="B31" ref-type="bibr">31</xref>).</p></sec></sec></sec><sec id="S2"><title>Epidemiology Features of hRSV Infection</title><p>Viral infections are the most important cause of acute lower respiratory tract infection (ALTRI), affecting mainly young children and the elderly (<xref rid="B32" ref-type="bibr">32</xref>, <xref rid="B33" ref-type="bibr">33</xref>). Up to date, the main agent causing this pathology is the hRSV (<xref rid="B33" ref-type="bibr">33</xref>&#x02013;<xref rid="B37" ref-type="bibr">37</xref>). Human RSV produces a broad spectrum of clinical manifestations, ranging from mild, such as rhinitis, to more serious symptoms that include bronchiolitis and pneumonia (<xref rid="B38" ref-type="bibr">38</xref>, <xref rid="B39" ref-type="bibr">39</xref>). Clinical symptoms not only are due hRSV but also involve host risk factors, such as preterm birth, immunosuppression, congenital heart disease, and chronic lung disease (<xref rid="B40" ref-type="bibr">40</xref>&#x02013;<xref rid="B43" ref-type="bibr">43</xref>). Importantly, it is known that almost 100% of children have been infected with hRSV before 2&#x02009;years old, due to the fact that this virus is highly contagious and efficient at disseminating from one individual to the next (<xref rid="B44" ref-type="bibr">44</xref>, <xref rid="B45" ref-type="bibr">45</xref>). Up to date, infections due to hRSV remain still as one of the most important global public health burdens affecting humans in all countries (<xref rid="B45" ref-type="bibr">45</xref>). Annually, approximately 33 millions new cases worldwide are associated to ALTRI caused by hRSV infection alone, affecting mainly children under 5&#x02009;years old (<xref rid="B33" ref-type="bibr">33</xref>, <xref rid="B46" ref-type="bibr">46</xref>). Moreover, hospitalization events due to a severe bronchiolitis or pneumonia caused by hRSV infection have increased and reached about a 10% of the total number of cases (<xref rid="B46" ref-type="bibr">46</xref>). Importantly, the annual cost of hospitalizations due to hRSV outbreaks is about 394 million USD, a situation that repeats every year (<xref rid="B33" ref-type="bibr">33</xref>, <xref rid="B47" ref-type="bibr">47</xref>).</p><p>In young children, the immune system fails to establish a protective response against hRSV, which leads to frequent re-infections (<xref rid="B33" ref-type="bibr">33</xref>, <xref rid="B47" ref-type="bibr">47</xref>&#x02013;<xref rid="B49" ref-type="bibr">49</xref>). Lack of protective immunity is explained by an impaired induction of cellular and humoral immune memory after the primary exposure to hRSV (<xref rid="B34" ref-type="bibr">34</xref>, <xref rid="B39" ref-type="bibr">39</xref>, <xref rid="B50" ref-type="bibr">50</xref>). Furthermore, hRSV is capable of modulating phagocytic cell function, leading to the respiratory immunopathology that is a characteristic of the infection by this virus (<xref rid="B44" ref-type="bibr">44</xref>).</p><p>The most severe clinical manifestation caused by hRSV is bronchiolitis (<xref rid="B51" ref-type="bibr">51</xref>), which is mainly characterized by a distal bronchiole inflammation and obstruction, which reduces the airflow into small airways and impairs the exhalation capacity (<xref rid="B52" ref-type="bibr">52</xref>). All these alterations promote an abnormal lung function that is manifested as airway hyperexpansion, increased mucus production, atelectasis, and wheezing (<xref rid="B52" ref-type="bibr">52</xref>, <xref rid="B53" ref-type="bibr">53</xref>). The bronchiolitis caused by hRSV infection also can produce long-term pathologies and sequelae, such as asthma and respiratory hyperreactivity (<xref rid="B54" ref-type="bibr">54</xref>).</p><p>After that hRSV encounters the airway epithelial cells (AECs), this virus gets in contact with innate immune cells, such as monocytes, M&#x003a6;, and DCs located at the lung tissue (<xref rid="B10" ref-type="bibr">10</xref>). These immune cells produce significant amounts of pro- inflammatory cytokines after a viral infection that is involved in controlling adaptive immunity by their interaction with helper T cells (<xref rid="B10" ref-type="bibr">10</xref>, <xref rid="B55" ref-type="bibr">55</xref>). In addition to contributing to the clearance of microbial pathogens, monocytes and M&#x003a6;s also play an important role as APCs to prime T lymphocytes (<xref rid="B56" ref-type="bibr">56</xref>). Consistently with this notion, monocytes, M&#x003a6;s and DCs not only are involved during the acute inflammatory phase of hRSV-induced bronchiolitis but also contribute to the promotion of reactive airway disease caused by this virus (<xref rid="B57" ref-type="bibr">57</xref>&#x02013;<xref rid="B59" ref-type="bibr">59</xref>).</p></sec><sec id="S3"><title>Monocytes are Required to Initiate the Immune Response Against hRSV</title><p>Monocytes are part of the first line of the host immune defense against viral pathogens (<xref rid="B60" ref-type="bibr">60</xref>). In response to infection with hRSV, human AEC-derived cell lines secrete cytokines and chemokines <italic>in vitro</italic>, including IL-6, IL-8, CCL2, CCL3, and CCL5 that promote the recruitment of monocytes and eosinophils to the site of infection (Figure <xref ref-type="fig" rid="F1">1</xref>) (<xref rid="B60" ref-type="bibr">60</xref>, <xref rid="B61" ref-type="bibr">61</xref>). In addition, infection of BEAS2B cells (human lung epithelial cell line) with hRSV kept them from inhibiting the secretion of pro-inflammatory cytokines by monocytes, such as TNF&#x003b1; (<xref rid="B62" ref-type="bibr">62</xref>). During homeostasis, AECs are able to inhibit the function of inflammatory monocytes, a feature that is impaired in hRSV-infected AECs (<xref rid="B62" ref-type="bibr">62</xref>). Interestingly, monocytes can be directly infected by hRSV, reducing the expression of the intercellular adhesion molecule 1 and its ligand, the lymphocyte function-associated antigen 1, which alters the collaboration between monocytes and other immune cells (<xref rid="B10" ref-type="bibr">10</xref>, <xref rid="B63" ref-type="bibr">63</xref>). These observations suggest that monocytes infected with hRSV can display a reduced capacity to induce a protective immune response against hRSV (<xref rid="B10" ref-type="bibr">10</xref>).</p><fig id="F1" position="float"><label>Figure 1</label><caption><p>Human respiratory syncytial virus (hRSV) infection alters the function of monocytes and promotes their infiltration into the lungs. During the steady state (left), the main monocytes subset found in lungs are CD14<sup>+</sup>CD16<sup>&#x02212;</sup>. During hRSV infection (right), infected airway epithelial cells secrete IL-6, IL-8, CCL2, CCL3, and CCL5, which promote monocytes and eosinophils infiltration into the airways. In addition, blood monocytes express increased levels of CD14 and HLA-ABC and reduced levels of HLA-DR, which is associated with severe bronchiolitis.</p></caption><graphic xlink:href="fimmu-08-01643-g001"/></fig><p>Patients infected with hRSV show a frequency increase for CD14<sup>+</sup>CD16<sup>+</sup> monocytes in the blood (<xref rid="B37" ref-type="bibr">37</xref>). Furthermore, an increase of CD14 expression has been observed for all the monocyte subsets (Figure <xref ref-type="fig" rid="F1">1</xref>) (<xref rid="B37" ref-type="bibr">37</xref>, <xref rid="B64" ref-type="bibr">64</xref>), suggesting that these cells can display an enhanced capacity to secrete cytokines and to migrate into the airways, probably to replace alveolar M&#x003a6; during hRSV infection (<xref rid="B37" ref-type="bibr">37</xref>, <xref rid="B64" ref-type="bibr">64</xref>). Moreover, monocytes from hRSV-infected patients show a diminished expression of HLA-DR (Figure <xref ref-type="fig" rid="F1">1</xref>), correlating with disease severity (<xref rid="B37" ref-type="bibr">37</xref>, <xref rid="B65" ref-type="bibr">65</xref>).</p><p>As mentioned above, hRSV infection causes bronchiolitis in children under 2&#x02009;years old (<xref rid="B66" ref-type="bibr">66</xref>). Moreover, the pathology is worsened by some cytokines produced by monocytes during the early state of hRSV infection (<xref rid="B67" ref-type="bibr">67</xref>). Monocytes from of hRSV-infected patients presenting bronchiolitis in the convalescent stage of the infection secreted large amounts of IL-10 in response to stimulation with LPS and IFN-&#x003b3; <italic>in vitro</italic> (<xref rid="B67" ref-type="bibr">67</xref>). Furthermore, authors showed a significant correlation between the monocyte-produced IL-10 and the number of wheezing episodes (<xref rid="B10" ref-type="bibr">10</xref>, <xref rid="B67" ref-type="bibr">67</xref>).</p><p>Similar to M&#x003a6; and DCs, monocytes express TLR8 that promotes endosomal activation and IL-12p70 release upon binding to viral RNA (<xref rid="B68" ref-type="bibr">68</xref>). Monocytes derived from hRSV-infected infants displayed reduced expression of TLR8 during the acute phase of infection (<xref rid="B68" ref-type="bibr">68</xref>). Additionally, this study showed that monocytes from hRSV-infected infants produced reduced levels of TNF-&#x003b1; as compared to monocytes from healthy controls (<xref rid="B68" ref-type="bibr">68</xref>). Taken together, these results suggest that hRSV infection interferes with the normal expression of TLR8 and perhaps with the cytokines production that are important to initiate the immune response against hRSV (<xref rid="B68" ref-type="bibr">68</xref>).</p><p>The data relative to the role of monocytes during the immune response induced by the hRSV infection suggest that these cells are important to initiate the immunity against this pathogen. Further, monocytes are also involved in the development of bronchiolitis and the recurrent wheezing. Thus, it is likely that these cells could contribute to chronic respiratory sequelae caused by hRSV, such as asthma and airway hyperreactivity.</p></sec><sec id="S4"><title>Alveolar Macrophages (AMs) are Crucial to Control hRSV-Caused Disease</title><p>Lung-resident macrophages consist of two distinct populations namely (1) AMs and (2) interstitial macrophages (IMs) (<xref rid="B69" ref-type="bibr">69</xref>). AMs locate in the luminal surface, while IMs reside in the interstitial space of the lung parenchyma (<xref rid="B70" ref-type="bibr">70</xref>). AMs are the most abundant phagocytic resident cells in the lungs, which uptake foreign particles, remove cellular debris, initiate immune responses against pathogens and contribute to restoring homeostasis in the lung epithelium (<xref rid="B70" ref-type="bibr">70</xref>). During the steady state (Figure <xref ref-type="fig" rid="F2">2</xref>), AMs can display an immunosuppressive effect by directly inhibiting the antigen-presenting function of lung DCs (<xref rid="B71" ref-type="bibr">71</xref>) or by inducing CD4<sup>+</sup> T cell unresponsiveness in an antigen-specific manner (<xref rid="B72" ref-type="bibr">72</xref>). Furthermore, AMs can secrete several immunomodulatory molecules, such as IL-10, nitric oxide, prostaglandins, and transforming growth factor-&#x003b2; (Figure <xref ref-type="fig" rid="F2">2</xref>), which reduce inflammation in the lungs (<xref rid="B73" ref-type="bibr">73</xref>).</p><fig id="F2" position="float"><label>Figure 2</label><caption><p>Alveolar macrophage (AM) function during homeostasis or infection by human respiratory syncytial virus (hRSV). During the steady state (left), AMs perform an anti-inflammatory function leading to immune tolerance. AM suppresses the response of T cell in an antigen-dependent manner and secretes cytokines as IL-10 and transforming growth factor-&#x003b2; (TGF&#x003b2;). Also, AMs impair dendritic cells (DCs) activity inhibiting T cell presentation. Under hRSV infection (right), AMs can recognize the virus by TLR4 and respond by secreting type I IFNs that induce an antiviral state in epithelial cells. In addition, the secretion of pro-inflammatory cytokines promotes recruitment of inflammatory monocytes, CD8<sup>+</sup> T cells, and NK cells that contribute with viral clearance.</p></caption><graphic xlink:href="fimmu-08-01643-g002"/></fig><p>The role of AMs during hRSV infection has been characterized in murine models by depleting these cells through the administration of liposomes containing clodronate, a molecule that promotes the apoptosis of AMs (<xref rid="B70" ref-type="bibr">70</xref>, <xref rid="B74" ref-type="bibr">74</xref>, <xref rid="B75" ref-type="bibr">75</xref>). It was shown that AMs are crucial for the clearance of hRSV and for the control of lung inflammation (<xref rid="B70" ref-type="bibr">70</xref>). The depletion of AMs during hRSV infection leads to an increased viral replication and an exacerbated lung immunopathology (<xref rid="B70" ref-type="bibr">70</xref>). These results were consistent with a dramatic increase of neutrophils and inflammatory DCs recruitment to the lungs (<xref rid="B70" ref-type="bibr">70</xref>, <xref rid="B74" ref-type="bibr">74</xref>). Then, in mice, AMs display a protective function during hRSV infection and contribute to attenuating lung inflammation and bronchiolitis triggered by this pathogen (<xref rid="B76" ref-type="bibr">76</xref>). Similar results were obtained in New Zealand Black (NZB) mice, which lack normal macrophage function and show an enhanced lung immunopathology upon hRSV exposure (<xref rid="B76" ref-type="bibr">76</xref>). Although the mechanisms responsible for the beneficial effect of AMs to control hRSV infection remain unknown, the available data suggest that the phagocytic and microbicidal capacity of AMs together with the secretion of type I IFN are the main elements contributing to the protection against this virus (<xref rid="B76" ref-type="bibr">76</xref>).</p><p>Alveolar macrophages are the main producers of type I IFNs in the airways during hRSV infection, even more than other cells, such as epithelial cells and pDCs (<xref rid="B75" ref-type="bibr">75</xref>). Type I IFN production by AMs is triggered by hRSV recognition and mediated by cytosolic mitochondrial antiviral signaling protein-coupled retinoic acid-inducible gene 1 (RIG-I)-like receptors (RLRs) (<xref rid="B77" ref-type="bibr">77</xref>). The type I IFN production promotes the monocytes-derived inflammatory cells recruitment (Figure <xref ref-type="fig" rid="F2">2</xref>), which further contributes to controlling hRSV infection and reducing lung pathology (<xref rid="B77" ref-type="bibr">77</xref>).</p><p>On the other hand, <italic>ex vivo</italic> experiments showed that hRSV infects both murine and human AMs (<xref rid="B78" ref-type="bibr">78</xref>). However, in both cases, the infection failed to lead to an increase of viral particle production (<xref rid="B70" ref-type="bibr">70</xref>, <xref rid="B79" ref-type="bibr">79</xref>). These results suggest that the infection of AMs by hRSV might be abortive, allowing that AMs maintain a sentinel activity. Further, it is thought that abortive replication may allow AMs to resist the effects of hRSV NS protein, which inhibits the activity of RIG-I-like receptors (RLR) (<xref rid="B77" ref-type="bibr">77</xref>). Along these lines, AMs can restrict hRSV replication even in the absence of type I IFNs (<xref rid="B75" ref-type="bibr">75</xref>). However, the exposure of AMs to hRSV can result in a reduced phagocytic capacity during subsequent infections (<xref rid="B79" ref-type="bibr">79</xref>).</p><p>Moreover, AMs are essential for the activation of the early immune response against hRSV (<xref rid="B70" ref-type="bibr">70</xref>). Infection of human AMs by hRSV leads to the secretion of several pro-inflammatory cytokines, such as IL-6, TNF-&#x003b1;, IL-1&#x003b2;, and IL-8 (<xref rid="B78" ref-type="bibr">78</xref>, <xref rid="B80" ref-type="bibr">80</xref>, <xref rid="B81" ref-type="bibr">81</xref>). Conversely, similar experiments have described the secretion of IL-10 by these cells (<xref rid="B82" ref-type="bibr">82</xref>). The AMs response to hRSV is mediated mainly by the activation of NF-&#x003ba;B through recognition of non-replicative viral particles and surface viral proteins by TLR4 at early times postinfection (Figure <xref ref-type="fig" rid="F2">2</xref>) (<xref rid="B83" ref-type="bibr">83</xref>). Based on the available data about the role of TLR4 in the infection with hRSV, it has been hypothesized that in the beginning, surfactant protein A-opsonized hRSV can bind to TLR4 expressed on the surface of alveolar epithelial cells and AMs (<xref rid="B84" ref-type="bibr">84</xref>). Next, additional TLR4 and CX3CR1 molecules are recruited to the virus attachment site (<xref rid="B84" ref-type="bibr">84</xref>). Then, the hRSV F and G proteins interact with TLR4 and CX3CR1, respectively. Furthermore, both proteins interact with heparan sulfate structures (<xref rid="B84" ref-type="bibr">84</xref>), an interaction that is followed by the recruitment of caveolin-1 and the formation of caveolae with the subsequently recruitment of RhoA to the binding site (<xref rid="B84" ref-type="bibr">84</xref>). Moreover, it has been suggested that the binding of the hRSV F protein to TLR4 may activate the signaling pathway for this receptor and NF-&#x003ba;B translocation (<xref rid="B84" ref-type="bibr">84</xref>, <xref rid="B85" ref-type="bibr">85</xref>). However, the role of TLR4 during the hRSV entry into target cells remains controversial, as well as the interaction with viral proteins that trigger the activation of the NF-&#x003ba;B pathway (<xref rid="B86" ref-type="bibr">86</xref>). A study performed in TLR4-positive cells (HEK 293 reporter cell lines) showed that infection with hRSV does not activate the NF-&#x003ba;B signaling pathway through the TLR4/MD-2/CD14 complex (<xref rid="B87" ref-type="bibr">87</xref>). However, in the context of the AM-directed immune response, studies have shown that in the absence of TLR4, the NF-&#x003ba;B signaling pathway is not activated (<xref rid="B83" ref-type="bibr">83</xref>) and that the latter is required for the polarization of M&#x003a6; toward the M2 phenotype (<xref rid="B88" ref-type="bibr">88</xref>). On the other hand, the establishment of this initial condition allows an effective lymphocyte recruitment and proper antiviral activity. Along these lines, human neonatal AMs infected with hRSV showed an impairment in the IFN-&#x003b3; and IL-12 production (<xref rid="B81" ref-type="bibr">81</xref>). An inefficient secretion of IFN-&#x003b3; has been associated with an increase of severe illness in infants (<xref rid="B89" ref-type="bibr">89</xref>). Considering that IFN-&#x003b3; is necessary for the activation of AMs, a reduced production of IFN-&#x003b3; in neonates has been observed to impair AMs activation, affecting the phagocytic capacity of these cells and exacerbating the hRSV-mediated bronchiolitis (<xref rid="B90" ref-type="bibr">90</xref>, <xref rid="B91" ref-type="bibr">91</xref>). Also, an impaired AMs function reduces the T and NKT cells recruitment to the lungs, contributing to higher viral loads (<xref rid="B91" ref-type="bibr">91</xref>).</p><p>According with the data described above, AMs are important for the elicitation of an early immune response against hRSV, contributing to the viral clearance mainly mediated by the type I IFN secretion and the coordination of the adaptive response against this pathogen. Thus, an impaired function or absence of AMs can increase hRSV-induced bronchiolitis, both in mouse models and infants.</p><p>In contrast to the significant research efforts to understand the role of AMs during the infection with hRSV, the participation of IMs has only been poorly studied (<xref rid="B92" ref-type="bibr">92</xref>). Qi et al. evaluated the role of AMs and IMs in the production of IL-33 during hRSV infection (<xref rid="B93" ref-type="bibr">93</xref>). This study showed that the absolute number of IMs in lungs of hRSV-infected mice remained constant during the hRSV infection, in contrast to the increase observed for the absolute number of AMs (<xref rid="B93" ref-type="bibr">93</xref>). Furthermore, IMs from lungs of hRSV-infected mice showed an increase in the expression of both TLR3 and TLR7 mRNA (<xref rid="B93" ref-type="bibr">93</xref>). Considering that the number of IL-33-producing IMs in the lungs of mice was affected by hRSV infection, authors concluded that the IMs may not be the source of IL-33 during hRSV infection (<xref rid="B93" ref-type="bibr">93</xref>).</p><p>Therefore, additional studies are required to better understand the contribution of IMs to hRSV infection and pathogenesis.</p></sec><sec id="S5"><title>DCs as Commanders of the Immune Response During hRSV Infection</title><p>The infection with hRSV can induce different immune responses depending on the type of DC subset infected (<xref rid="B94" ref-type="bibr">94</xref>). According to this notion, it has been described that hRSV infection promotes CDs maturation by increasing the expression of CD80, CD86, CD40, and MHC-II in the lungs, which leads to a decrease of phagocyte function (<xref rid="B95" ref-type="bibr">95</xref>). Moreover, some studies in mice have reported that during the acute phase of hRSV infection, the frequency of mature DCs in the lungs is increased (<xref rid="B95" ref-type="bibr">95</xref>). On the other hand, it has been shown that hRSV has the capacity to infect and replicate inside DCs but in a non-productive manner (<xref rid="B96" ref-type="bibr">96</xref>&#x02013;<xref rid="B98" ref-type="bibr">98</xref>). Importantly, it has been described that toll-like receptors expressed by DCs can interact with hRSV proteins. TLR-2 interacts with the viral fusion glycoprotein (F) and TLR-4 with both the F and the attachment G protein (<xref rid="B99" ref-type="bibr">99</xref>, <xref rid="B100" ref-type="bibr">100</xref>). TLR4 activation promotes the secretion of IL-6 and TNF-&#x003b1;, as well as antigen cross-presentation <italic>in vivo</italic> and <italic>in vitro</italic> (<xref rid="B101" ref-type="bibr">101</xref>). Additionally, hRSV G glycoprotein interacts with DC- and L-SIGN, inducing both DC/L-SIGN-dependent and -independent phosphorylation of ERK1 and ERK2. As a result, DCs activation is impaired (<xref rid="B102" ref-type="bibr">102</xref>). This mechanism can be considered as a possible explanation for the reduced immunity induced by hRSV reinfections.</p><p>To understand as to how DCs become infected with hRSV, <italic>in vitro</italic> and <italic>in vivo</italic> experiments were performed in mouse models, which showed the contribution of Fc&#x003b3; receptors (Fc&#x003b3;Rs), mainly Fc&#x003b3;RIII, to infection by this virus (<xref rid="B103" ref-type="bibr">103</xref>). Human RSV-infected Fc&#x003b3;RIII KO mice showed reduced airway inflammation as compared to infected wild-type mice, suggesting that Fc&#x003b3;RIII plays a pro-inflammatory role during hRSV infection (<xref rid="B103" ref-type="bibr">103</xref>). On the other hand, it is known that hRSV infection induces only weak immune memory in the host (<xref rid="B50" ref-type="bibr">50</xref>). To understand this phenomenon, a possible impairment of the immunological synapsis between hRSV-infected DCs and T cells was evaluated <italic>in vitro</italic>. It was observed that hRSV infection of DCs not only impaired the assembly of the immunological synapsis with T cells but also the activation of na&#x000ef;ve antigen-specific T cells (<xref rid="B50" ref-type="bibr">50</xref>, <xref rid="B104" ref-type="bibr">104</xref>). The hRSV virulence factor that seems responsible for the inhibition of immunological synapse assembly is the nucleoprotein (N) (<xref rid="B104" ref-type="bibr">104</xref>). The N protein was found on the DCs membrane and by itself could interfere with the assembly of the immunological synapsis (<xref rid="B104" ref-type="bibr">104</xref>). Further, the N protein was located nearby to the TCR&#x02013;pMHC complexes at the DC-T cell synapse interface (<xref rid="B50" ref-type="bibr">50</xref>, <xref rid="B104" ref-type="bibr">104</xref>).</p><p>On the other hand, it has been reported that the mTOR protein on bone marrow-derived dendritic cells (BMDCs) plays an important role during hRSV infection (<xref rid="B105" ref-type="bibr">105</xref>). According to this notion, mTOR inhibition by rapamycin in hRSV-infected BMDCs decreased the number of CD8<sup>+</sup>CD44<sup>high</sup> T cells, suggesting that mTOR is necessary for the proliferation of the T cell memory subset (<xref rid="B105" ref-type="bibr">105</xref>). Moreover, the treatment of the hRSV-infected BMDCs with rapamycin did not affect maturation and increased the survival when DCs were cocultured with T cells, suggesting that this phenomenon requires the contact of both cell types (<xref rid="B105" ref-type="bibr">105</xref>).</p><p>CD103<sup>+</sup> cDCs are the most prevalent population of DCs in the lungs, which locate directly underneath the airway epithelium (<xref rid="B14" ref-type="bibr">14</xref>). CD103<sup>+</sup> cDCs express the integrin &#x003b1;<sub>E</sub>&#x003b2;<sub>7</sub> and are found mainly at the lamina basal of the bronchial epithelia and arterioles (<xref rid="B106" ref-type="bibr">106</xref>). This DCs subset efficiently loads virus-derived peptides onto MHC-I molecules, inducing a potent proliferation of na&#x000ef;ve CD8<sup>+</sup> T cells (Figure <xref ref-type="fig" rid="F3">3</xref>) (<xref rid="B107" ref-type="bibr">107</xref>). Therefore, CD103<sup>+</sup> cDCs work as key mediators of immunity to intracellular pathogens infecting the lungs (<xref rid="B108" ref-type="bibr">108</xref>, <xref rid="B109" ref-type="bibr">109</xref>). In several studies with hRSV, neonatal mice have been used to better compare the human clinical features with mouse models of the disease (<xref rid="B110" ref-type="bibr">110</xref>). CD103<sup>+</sup> DCs from neonatal mice infected with hRSV showed lower expression of co-stimulatory molecules, CD80 and CD86, as compared to the adult counterparts, affecting the T cell synapsis quality (<xref rid="B110" ref-type="bibr">110</xref>). For this reason, neonatal mice infected with hRSV generated a distinct CD8<sup>+</sup> T cell response as compared to adult mice, suggesting a key role of CD103<sup>+</sup> DCs (<xref rid="B110" ref-type="bibr">110</xref>). Furthermore, the immunization with F virus-like particles (VLP) of hRSV-infected mice showed high levels of CD103<sup>+</sup> DCs in bronchoalveolar lavage fluids (BALFs) and lungs (<xref rid="B23" ref-type="bibr">23</xref>). Moreover, the mediastinal LN from F VLP-immunized mice showed higher levels of CD103<sup>+</sup> DCs and resident CD8&#x003b1;<sup>+</sup> DCs (<xref rid="B23" ref-type="bibr">23</xref>). It is known that after hRSV infection is resolved, is possible to develop subsequent asthma during childhood (<xref rid="B111" ref-type="bibr">111</xref>, <xref rid="B112" ref-type="bibr">112</xref>). Here, CD103<sup>+</sup> DCs play a protective role during asthma/allergic-related symptoms by producing IL-12 (<xref rid="B113" ref-type="bibr">113</xref>).</p><fig id="F3" position="float"><label>Figure 3</label><caption><p>Different roles of dendritic cells (DCs) subsets during human respiratory syncytial virus (hRSV) infection. During the steady state (upper), DCs subset maintain the lung homeostasis and when an infection occurs, they are capable to migrate to mediastinal lymph node to present antigens to T cells, promoting an immune response. Upon hRSV infection, plasmacytoid DCs (pDCs) increase in numbers, as well as the expression of co-stimulatory molecules, such as CD80, CD86. In addition, pDCs secretes high levels of IFN-&#x003b1; and PDL-2 expression is reduced. Moreover, in response to hRSV infection, CD11b<sup>+</sup> DCs fail to activate CD4<sup>+</sup> T cells leading a poor response against the virus. On the other hand, CD103<sup>+</sup> DCs show a lower expression of CD80 and CD86, which are required for an appropriate antiviral immune response.</p></caption><graphic xlink:href="fimmu-08-01643-g003"/></fig><p>As mentioned above, another DCs cell subset, CD11b<sup>+</sup> cDCs locate in the lung parenchyma (<xref rid="B114" ref-type="bibr">114</xref>, <xref rid="B115" ref-type="bibr">115</xref>). In addition to the uptake of extracellular pathogens, the main function of these cells is to present antigens to CD4<sup>+</sup> T cells (<xref rid="B116" ref-type="bibr">116</xref>). Studies were carried out in mice to understand the role of CD11b<sup>+</sup> DCs during hRSV infection. In lungs from mice infected with hRSV, an increase was observed for the frequency of CD11b<sup>+</sup> DCs (<xref rid="B114" ref-type="bibr">114</xref>). Moreover, it was determined that the ability of CD11b<sup>+</sup> DCs to migrate to LN remained intact (<xref rid="B114" ref-type="bibr">114</xref>). One of the mechanisms proposed for the accumulation of CD11b<sup>+</sup> DCs in the airways is that during hRSV infection, the high levels detected for CCL20 in the lungs can attract CD11b<sup>+</sup> CCR6<sup>+</sup> DCs (<xref rid="B117" ref-type="bibr">117</xref>, <xref rid="B118" ref-type="bibr">118</xref>). To evaluate the role of CD11b<sup>+</sup> CCR6<sup>+</sup> DCs during hRSV infection, studies were performed in CCR6-deficient mice, showing an increase of viral clearance, lower levels of Th2 pro-inflammatory cytokines, as well as reduced mucus production (<xref rid="B117" ref-type="bibr">117</xref>, <xref rid="B118" ref-type="bibr">118</xref>). Overall, these findings suggest that the CD11b<sup>+</sup> CCR6<sup>+</sup> DCs promote a Th2 immune response upon hRSV infection (<xref rid="B117" ref-type="bibr">117</xref>, <xref rid="B118" ref-type="bibr">118</xref>). Additional studies performed in the neonatal murine model described that lung CD11b<sup>+</sup> DCs express higher levels of the IL-4 &#x003b1; receptor (IL-4R&#x003b1;) as compared to adult mice (<xref rid="B119" ref-type="bibr">119</xref>). <italic>In vitro</italic> experiments using neonatal murine CD11b<sup>+</sup> DCs showed that IL-4R&#x003b1; promotes the differentiation of T cells into a Th2 phenotype (<xref rid="B119" ref-type="bibr">119</xref>). Furthermore, when the IL-4R&#x003b1; was deleted, maturation of these cells increased, suggesting that neonatal CD11b<sup>+</sup> DCs are less prone to maturation. This feature of neonatal DCs could impair their capacity to induce a protective hRSV-specific immune response (<xref rid="B119" ref-type="bibr">119</xref>). Similar results were observed <italic>in vivo</italic> experiments; however, the deletion of IL-4R&#x003b1; could be observed in several cells types including AMs, CD11b<sup>+</sup> DCs, and CD103<sup>+</sup> DCs (<xref rid="B119" ref-type="bibr">119</xref>).</p><p>Plasmacytoid DCs are the other prominent subset present in the lungs, which are an important source of IFN-&#x003b1;/&#x003b2;, fundamental antiviral cytokines during an infection, both in humans and mice (<xref rid="B120" ref-type="bibr">120</xref>, <xref rid="B121" ref-type="bibr">121</xref>). The role of this DCs subset was elucidated by performing experiments with hRSV-infected bone marrow-derived pDCs, which expressed high levels of IFN-&#x003b1;, CD80, and CD86 and lower PD-L2 levels (Figure <xref ref-type="fig" rid="F3">3</xref>) (<xref rid="B122" ref-type="bibr">122</xref>). Moreover, in the same study, authors showed that the number of pDCs was increased early after infection and then decreased with the resolution of the disease, suggesting that pDCs are required during early stages of infection by hRSV (<xref rid="B122" ref-type="bibr">122</xref>). Also, it has been demonstrated that when pDCs are depleted using a 120G8 antibody, the lungs of hRSV-infected mice displayed an enhanced inflammation consisting mainly of mononuclear cells and lymphocytes, together an increase of viral loads (<xref rid="B123" ref-type="bibr">123</xref>). Consistently with these findings, it was observed that BALFs from hRSV-infected preterm born children showed reduced recruitment of pDCs into the lungs. These data are in agreement with the notion that low numbers of pDCs could work as a risk factor for severe bronchiolitis (<xref rid="B124" ref-type="bibr">124</xref>).</p><p>Additionally, three pDCs subsets have been characterized that include CD8&#x003b1;<sup>&#x02212;</sup>&#x003b2;<sup>&#x02212;</sup>, CD8&#x003b1;<sup>+</sup>&#x003b2;<sup>&#x02212;</sup>, and CD8&#x003b1;<sup>+</sup>&#x003b2;<sup>+</sup> (<xref rid="B125" ref-type="bibr">125</xref>). The frequency of these subsets is 61, 22, and 6% in the lungs of healthy mice, respectively (<xref rid="B125" ref-type="bibr">125</xref>). However, beside all the current knowledge about the role of the different subset of DCs during hRSV infection, there are no data about the contribution of these cells to the hRSV-induced pathology.</p><p>In summary, all DCs subsets seem to be important for an antiviral immune response. However, hRSV is able to modulate the function of these cells by promoting an imbalance between these subsets, which could be critical for the resolution of the disease caused by this virus.</p></sec><sec id="S6"><title>Concluding Remarks</title><p>The MPS consists of a family of cells that include monocytes, M&#x003a6;, and DCs, among others (<xref rid="B1" ref-type="bibr">1</xref>&#x02013;<xref rid="B3" ref-type="bibr">3</xref>). These cells are characterized by their high mobility, phagocytic capacity, and ability to secrete a broad spectrum of immunomodulatory molecules (<xref rid="B2" ref-type="bibr">2</xref>). MPS exerts several functions in health and disease in several tissues (<xref rid="B2" ref-type="bibr">2</xref>). In the lungs, MPS plays an important role in the maintenance of homeostasis during steady state. During an infection, the MPS works as the first line of immune response against pathogens (<xref rid="B2" ref-type="bibr">2</xref>). Among the respiratory pathogens, hRSV is considered the most important cause of respiratory illness in infants and young children (<xref rid="B33" ref-type="bibr">33</xref>). The main severe clinical manifestation due to the hRSV infection is bronchiolitis (<xref rid="B33" ref-type="bibr">33</xref>). In this context, the MPS can contribute to the development of the immunopathology induced by hRSV (<xref rid="B10" ref-type="bibr">10</xref>). This viral pathogen is able to infect the MPS cells, altering the proper immune response required for viral clearance and the later acquisition of an antiviral immune memory (<xref rid="B10" ref-type="bibr">10</xref>). During the acute phase of the hRSV infection, monocytes are important to initiate the innate immune response, secreting cytokines and chemokines that recruit other immune cells, such as M&#x003a6;, eosinophils, and neutrophils (<xref rid="B126" ref-type="bibr">126</xref>). The normal function of monocytes during hRSV infection can be impaired not only by the pathogen itself but also by the contact with virus-infected AECs, contributing to the development of severe bronchiolitis (<xref rid="B62" ref-type="bibr">62</xref>).</p><p>During hRSV infection, M&#x003a6;s play a protective role against infection and, finally, these cells are required for proper virus clearance (<xref rid="B77" ref-type="bibr">77</xref>). This notion is supported by experimental data obtained from various experimental models, such as neonatal mice and M&#x003a6;-depleted animals.</p><p>One of the effector mechanisms of M&#x003a6;s is the secretion of IFN-&#x003b3; and IL-12, which are reduced in human neonates infected by hRSV, contributing to development of bronchiolitis (<xref rid="B81" ref-type="bibr">81</xref>). Also, the inefficient recruitment of T and NKT cells into the airways (<xref rid="B91" ref-type="bibr">91</xref>) contributes to the development of bronchiolitis. As a consequence, there is a significant decrease of the protective capacity of the immune response triggered by hRSV and promoting virus spreading (<xref rid="B91" ref-type="bibr">91</xref>).</p><p>The ability of hRSV to infect DCs seems to be a major virulence mechanism used by this pathogen. The hRSV-infection of DCs impairs the correct immunological synapsis, which is required for T cell activation (<xref rid="B104" ref-type="bibr">104</xref>). These findings may contribute to explaining the lack of an effective immunological memory against hRSV, which allow subsequent reinfections throughout life. Moreover, pDCs are the major source of type I IFNs, cytokines necessary to induce an appropriate antiviral immune response (<xref rid="B122" ref-type="bibr">122</xref>). Consistently with a lack of protective immunity to hRSV, DCs infected by this virus show an impaired capacity to produce type I IFNs (<xref rid="B122" ref-type="bibr">122</xref>). Based on the current knowledge relative to the role of DCs in the hRSV-infection, these cells could be important for the promotion of an exacerbation of the inflammation during bronchiolitis. Besides the actual knowledge about the MPS in the hRSV immunopathology, is still necessary to further understand the mechanisms involved in the impairment of MPS function by hRSV virulence factors.</p></sec><sec id="S7"><title>Author Contributions</title><p>AK wrote, revised, and edited the article and figures. KB, JE, RP, and EJ wrote the article and drew the figures.</p></sec><sec id="S8"><title>Conflict of Interest Statement</title><p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p></sec></body><back><fn-group><fn fn-type="financial-disclosure"><p><bold>Funding.</bold> The grants are Millennium Institute in Immunology and Immunotherapy and Comisi&#x000f3;n Nacional de Investigaci&#x000f3;n Cient&#x000ed;fica y Tecnol&#x000f3;gica (CONICYT) CONICYT/FONDECYT POSTDOCTORADO No. 3150559.</p></fn></fn-group><ref-list><title>References</title><ref id="B1"><label>1</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van Furth</surname><given-names>R</given-names></name><name><surname>Cohn</surname><given-names>ZA</given-names></name></person-group>. <article-title>The origin and kinetics of mononuclear phagocytes</article-title>. <source>J Exp Med</source> (<year>1968</year>) <volume>128</volume>(<issue>3</issue>):<fpage>415</fpage>&#x02013;<lpage>35</lpage>.<pub-id pub-id-type="doi">10.1084/jem.128.3.415</pub-id><?supplied-pmid 5666958?><pub-id pub-id-type="pmid">5666958</pub-id></mixed-citation></ref><ref id="B2"><label>2</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hume</surname><given-names>DA</given-names></name></person-group>. <article-title>The mononuclear phagocyte system</article-title>. <source>Curr Opin Immunol</source> (<year>2006</year>) <volume>18</volume>(<issue>1</issue>):<fpage>49</fpage>&#x02013;<lpage>53</lpage>.<pub-id pub-id-type="doi">10.1016/j.coi.2005.11.008</pub-id><?supplied-pmid 16338128?><pub-id pub-id-type="pmid">16338128</pub-id></mixed-citation></ref><ref id="B3"><label>3</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hume</surname><given-names>DA</given-names></name></person-group>. <article-title>Differentiation and heterogeneity in the mononuclear phagocyte system</article-title>. <source>Mucosal Immunol</source> (<year>2008</year>) <volume>1</volume>(<issue>6</issue>):<fpage>432</fpage>&#x02013;<lpage>41</lpage>.<pub-id pub-id-type="doi">10.1038/mi.2008.36</pub-id><?supplied-pmid 19079210?><pub-id pub-id-type="pmid">19079210</pub-id></mixed-citation></ref><ref id="B4"><label>4</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Geissmann</surname><given-names>F</given-names></name><name><surname>Jung</surname><given-names>S</given-names></name><name><surname>Littman</surname><given-names>DR</given-names></name></person-group>. <article-title>Blood monocytes consist of two principal subsets with distinct migratory properties</article-title>. <source>Immunity</source> (<year>2003</year>) <volume>19</volume>(<issue>1</issue>):<fpage>71</fpage>&#x02013;<lpage>82</lpage>.<pub-id pub-id-type="doi">10.1016/S1074-7613(03)00174-2</pub-id><?supplied-pmid 12871640?><pub-id pub-id-type="pmid">12871640</pub-id></mixed-citation></ref><ref id="B5"><label>5</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chow</surname><given-names>A</given-names></name><name><surname>Brown</surname><given-names>BD</given-names></name><name><surname>Merad</surname><given-names>M</given-names></name></person-group>. <article-title>Studying the mononuclear phagocyte system in the molecular age</article-title>. <source>Nat Rev Immunol</source> (<year>2011</year>) <volume>11</volume>(<issue>11</issue>):<fpage>788</fpage>&#x02013;<lpage>98</lpage>.<pub-id pub-id-type="doi">10.1038/nri3087</pub-id><?supplied-pmid 22025056?><pub-id pub-id-type="pmid">22025056</pub-id></mixed-citation></ref><ref id="B6"><label>6</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hull</surname><given-names>TD</given-names></name><name><surname>Agarwal</surname><given-names>A</given-names></name><name><surname>George</surname><given-names>JF</given-names></name></person-group>. <article-title>The mononuclear phagocyte system in homeostasis and disease: a role for heme oxygenase-1</article-title>. <source>Antioxid Redox Signal</source> (<year>2014</year>) <volume>20</volume>(<issue>11</issue>):<fpage>1770</fpage>&#x02013;<lpage>88</lpage>.<pub-id pub-id-type="doi">10.1089/ars.2013.5673</pub-id><?supplied-pmid 24147608?><pub-id pub-id-type="pmid">24147608</pub-id></mixed-citation></ref><ref id="B7"><label>7</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zaslona</surname><given-names>Z</given-names></name><name><surname>Wilhelm</surname><given-names>J</given-names></name><name><surname>Cakarova</surname><given-names>L</given-names></name><name><surname>Marsh</surname><given-names>LM</given-names></name><name><surname>Seeger</surname><given-names>W</given-names></name><name><surname>Lohmeyer</surname><given-names>J</given-names></name><etal/></person-group>
<article-title>Transcriptome profiling of primary murine monocytes, lung macrophages and lung dendritic cells reveals a distinct expression of genes involved in cell trafficking</article-title>. <source>Respir Res</source> (<year>2009</year>) <volume>10</volume>:<fpage>2</fpage>.<pub-id pub-id-type="doi">10.1186/1465-9921-10-2</pub-id><?supplied-pmid 19149869?><pub-id pub-id-type="pmid">19149869</pub-id></mixed-citation></ref><ref id="B8"><label>8</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rodero</surname><given-names>MP</given-names></name><name><surname>Poupel</surname><given-names>L</given-names></name><name><surname>Loyher</surname><given-names>PL</given-names></name><name><surname>Hamon</surname><given-names>P</given-names></name><name><surname>Licata</surname><given-names>F</given-names></name><name><surname>Pessel</surname><given-names>C</given-names></name><etal/></person-group>
<article-title>Immune surveillance of the lung by migrating tissue monocytes</article-title>. <source>Elife</source> (<year>2015</year>) <volume>4</volume>:<fpage>e07847</fpage>.<pub-id pub-id-type="doi">10.7554/eLife.07847</pub-id><?supplied-pmid 26167653?><pub-id pub-id-type="pmid">26167653</pub-id></mixed-citation></ref><ref id="B9"><label>9</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hettinger</surname><given-names>J</given-names></name><name><surname>Richards</surname><given-names>DM</given-names></name><name><surname>Hansson</surname><given-names>J</given-names></name><name><surname>Barra</surname><given-names>MM</given-names></name><name><surname>Joschko</surname><given-names>AC</given-names></name><name><surname>Krijgsveld</surname><given-names>J</given-names></name><etal/></person-group>
<article-title>Origin of monocytes and macrophages in a committed progenitor</article-title>. <source>Nat Immunol</source> (<year>2013</year>) <volume>14</volume>(<issue>8</issue>):<fpage>821</fpage>&#x02013;<lpage>30</lpage>.<pub-id pub-id-type="doi">10.1038/ni.2638</pub-id><?supplied-pmid 23812096?><pub-id pub-id-type="pmid">23812096</pub-id></mixed-citation></ref><ref id="B10"><label>10</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kimpen</surname><given-names>JL</given-names></name></person-group>
<article-title>Respiratory syncytial virus and asthma. The role of monocytes</article-title>. <source>Am J Respir Crit Care Med</source> (<year>2001</year>) <volume>163</volume>(<issue>3 Pt 2</issue>):<fpage>S7</fpage>&#x02013;<lpage>9</lpage>.<pub-id pub-id-type="doi">10.1164/ajrccm.163.supplement_1.2011110</pub-id><pub-id pub-id-type="pmid">11254544</pub-id></mixed-citation></ref><ref id="B11"><label>11</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sunderkotter</surname><given-names>C</given-names></name><name><surname>Nikolic</surname><given-names>T</given-names></name><name><surname>Dillon</surname><given-names>MJ</given-names></name><name><surname>Van Rooijen</surname><given-names>N</given-names></name><name><surname>Stehling</surname><given-names>M</given-names></name><name><surname>Drevets</surname><given-names>DA</given-names></name><etal/></person-group>
<article-title>Subpopulations of mouse blood monocytes differ in maturation stage and inflammatory response</article-title>. <source>J Immunol</source> (<year>2004</year>) <volume>172</volume>(<issue>7</issue>):<fpage>4410</fpage>&#x02013;<lpage>7</lpage>.<pub-id pub-id-type="doi">10.4049/jimmunol.172.7.4410</pub-id><?supplied-pmid 15034056?><pub-id pub-id-type="pmid">15034056</pub-id></mixed-citation></ref><ref id="B12"><label>12</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shi</surname><given-names>C</given-names></name><name><surname>Pamer</surname><given-names>EG</given-names></name></person-group>. <article-title>Monocyte recruitment during infection and inflammation</article-title>. <source>Nat Rev Immunol</source> (<year>2011</year>) <volume>11</volume>(<issue>11</issue>):<fpage>762</fpage>&#x02013;<lpage>74</lpage>.<pub-id pub-id-type="doi">10.1038/nri3070</pub-id><?supplied-pmid 21984070?><pub-id pub-id-type="pmid">21984070</pub-id></mixed-citation></ref><ref id="B13"><label>13</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Qu</surname><given-names>C</given-names></name><name><surname>Brinck-Jensen</surname><given-names>NS</given-names></name><name><surname>Zang</surname><given-names>M</given-names></name><name><surname>Chen</surname><given-names>K</given-names></name></person-group>. <article-title>Monocyte-derived dendritic cells: targets as potent antigen-presenting cells for the design of vaccines against infectious diseases</article-title>. <source>Int J Infect Dis</source> (<year>2014</year>) <volume>19</volume>:<fpage>1</fpage>&#x02013;<lpage>5</lpage>.<pub-id pub-id-type="doi">10.1016/j.ijid.2013.09.023</pub-id><?supplied-pmid 24216295?><pub-id pub-id-type="pmid">24216295</pub-id></mixed-citation></ref><ref id="B14"><label>14</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baharom</surname><given-names>F</given-names></name><name><surname>Rankin</surname><given-names>G</given-names></name><name><surname>Blomberg</surname><given-names>A</given-names></name><name><surname>Smed-Sorensen</surname><given-names>A</given-names></name></person-group>. <article-title>Human lung mononuclear phagocytes in health and disease</article-title>. <source>Front Immunol</source> (<year>2017</year>) <volume>8</volume>:<fpage>499</fpage>.<pub-id pub-id-type="doi">10.3389/fimmu.2017.00499</pub-id><?supplied-pmid 28507549?><pub-id pub-id-type="pmid">28507549</pub-id></mixed-citation></ref><ref id="B15"><label>15</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Idzkowska</surname><given-names>E</given-names></name><name><surname>Eljaszewicz</surname><given-names>A</given-names></name><name><surname>Miklasz</surname><given-names>P</given-names></name><name><surname>Musial</surname><given-names>WJ</given-names></name><name><surname>Tycinska</surname><given-names>AM</given-names></name><name><surname>Moniuszko</surname><given-names>M</given-names></name></person-group>
<article-title>The role of different monocyte subsets in the pathogenesis of atherosclerosis and acute coronary syndromes</article-title>. <source>Scand J Immunol</source> (<year>2015</year>) <volume>82</volume>(<issue>3</issue>):<fpage>163</fpage>&#x02013;<lpage>73</lpage>.<pub-id pub-id-type="doi">10.1111/sji.12314</pub-id><pub-id pub-id-type="pmid">25997925</pub-id></mixed-citation></ref><ref id="B16"><label>16</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mosser</surname><given-names>DM</given-names></name><name><surname>Edwards</surname><given-names>JP</given-names></name></person-group>. <article-title>Exploring the full spectrum of macrophage activation</article-title>. <source>Nat Rev Immunol</source> (<year>2008</year>) <volume>8</volume>(<issue>12</issue>):<fpage>958</fpage>&#x02013;<lpage>69</lpage>.<pub-id pub-id-type="doi">10.1038/nri2448</pub-id><?supplied-pmid 19029990?><pub-id pub-id-type="pmid">19029990</pub-id></mixed-citation></ref><ref id="B17"><label>17</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gordon</surname><given-names>S</given-names></name></person-group>
<article-title>Alternative activation of macrophages</article-title>. <source>Nat Rev Immunol</source> (<year>2003</year>) <volume>3</volume>(<issue>1</issue>):<fpage>23</fpage>&#x02013;<lpage>35</lpage>.<pub-id pub-id-type="doi">10.1038/nri978</pub-id><pub-id pub-id-type="pmid">12511873</pub-id></mixed-citation></ref><ref id="B18"><label>18</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gordon</surname><given-names>S</given-names></name><name><surname>Pluddemann</surname><given-names>A</given-names></name></person-group>. <article-title>Tissue macrophages: heterogeneity and functions</article-title>. <source>BMC Biol</source> (<year>2017</year>) <volume>15</volume>(<issue>1</issue>):<fpage>53</fpage>.<pub-id pub-id-type="doi">10.1186/s12915-017-0392-4</pub-id><?supplied-pmid 28662662?><pub-id pub-id-type="pmid">28662662</pub-id></mixed-citation></ref><ref id="B19"><label>19</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Martinez</surname><given-names>FO</given-names></name><name><surname>Gordon</surname><given-names>S</given-names></name></person-group>. <article-title>The M1 and M2 paradigm of macrophage activation: time for reassessment</article-title>. <source>F1000Prime Rep</source> (<year>2014</year>) <volume>6</volume>:<fpage>13</fpage>.<pub-id pub-id-type="doi">10.12703/P6-13</pub-id><?supplied-pmid 24669294?><pub-id pub-id-type="pmid">24669294</pub-id></mixed-citation></ref><ref id="B20"><label>20</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sang</surname><given-names>Y</given-names></name><name><surname>Miller</surname><given-names>LC</given-names></name><name><surname>Blecha</surname><given-names>F</given-names></name></person-group>. <article-title>Macrophage polarization in virus-host interactions</article-title>. <source>J Clin Cell Immunol</source> (<year>2015</year>) <volume>6</volume>(<issue>2</issue>):<fpage>311</fpage>.<pub-id pub-id-type="doi">10.4172/2155-9899.1000311</pub-id><?supplied-pmid 26213635?><pub-id pub-id-type="pmid">26213635</pub-id></mixed-citation></ref><ref id="B21"><label>21</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stockwin</surname><given-names>LH</given-names></name><name><surname>McGonagle</surname><given-names>D</given-names></name><name><surname>Martin</surname><given-names>IG</given-names></name><name><surname>Blair</surname><given-names>GE</given-names></name></person-group>. <article-title>Dendritic cells: immunological sentinels with a central role in health and disease</article-title>. <source>Immunol Cell Biol</source> (<year>2000</year>) <volume>78</volume>(<issue>2</issue>):<fpage>91</fpage>&#x02013;<lpage>102</lpage>.<pub-id pub-id-type="doi">10.1046/j.1440-1711.2000.00888.x</pub-id><?supplied-pmid 10762408?><pub-id pub-id-type="pmid">10762408</pub-id></mixed-citation></ref><ref id="B22"><label>22</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Merad</surname><given-names>M</given-names></name><name><surname>Sathe</surname><given-names>P</given-names></name><name><surname>Helft</surname><given-names>J</given-names></name><name><surname>Miller</surname><given-names>J</given-names></name><name><surname>Mortha</surname><given-names>A</given-names></name></person-group>. <article-title>The dendritic cell lineage: ontogeny and function of dendritic cells and their subsets in the steady state and the inflamed setting</article-title>. <source>Annu Rev Immunol</source> (<year>2013</year>) <volume>31</volume>:<fpage>563</fpage>&#x02013;<lpage>604</lpage>.<pub-id pub-id-type="doi">10.1146/annurev-immunol-020711-074950</pub-id><?supplied-pmid 23516985?><pub-id pub-id-type="pmid">23516985</pub-id></mixed-citation></ref><ref id="B23"><label>23</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>KH</given-names></name><name><surname>Lee</surname><given-names>YT</given-names></name><name><surname>Hwang</surname><given-names>HS</given-names></name><name><surname>Kwon</surname><given-names>YM</given-names></name><name><surname>Kim</surname><given-names>MC</given-names></name><name><surname>Ko</surname><given-names>EJ</given-names></name><etal/></person-group>
<article-title>Virus-like particle vaccine containing the F protein of respiratory syncytial virus confers protection without pulmonary disease by modulating specific subsets of dendritic cells and effector T cells</article-title>. <source>J Virol</source> (<year>2015</year>) <volume>89</volume>(<issue>22</issue>):<fpage>11692</fpage>&#x02013;<lpage>705</lpage>.<pub-id pub-id-type="doi">10.1128/JVI.02018-15</pub-id><?supplied-pmid 26355098?><pub-id pub-id-type="pmid">26355098</pub-id></mixed-citation></ref><ref id="B24"><label>24</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mildner</surname><given-names>A</given-names></name><name><surname>Jung</surname><given-names>S</given-names></name></person-group>. <article-title>Development and function of dendritic cell subsets</article-title>. <source>Immunity</source> (<year>2014</year>) <volume>40</volume>(<issue>5</issue>):<fpage>642</fpage>&#x02013;<lpage>56</lpage>.<pub-id pub-id-type="doi">10.1016/j.immuni.2014.04.016</pub-id><?supplied-pmid 24837101?><pub-id pub-id-type="pmid">24837101</pub-id></mixed-citation></ref><ref id="B25"><label>25</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sato</surname><given-names>K</given-names></name><name><surname>Fujita</surname><given-names>S</given-names></name></person-group>
<article-title>Dendritic cells: nature and classification</article-title>. <source>Allergol Int</source> (<year>2007</year>) <volume>56</volume>(<issue>3</issue>):<fpage>183</fpage>&#x02013;<lpage>91</lpage>.<pub-id pub-id-type="doi">10.2332/allergolint.R-06-139</pub-id><pub-id pub-id-type="pmid">17646733</pub-id></mixed-citation></ref><ref id="B26"><label>26</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boltjes</surname><given-names>A</given-names></name><name><surname>van Wijk</surname><given-names>F</given-names></name></person-group>. <article-title>Human dendritic cell functional specialization in steady-state and inflammation</article-title>. <source>Front Immunol</source> (<year>2014</year>) <volume>5</volume>:<fpage>131</fpage>.<pub-id pub-id-type="doi">10.3389/fimmu.2014.00131</pub-id><?supplied-pmid 24744755?><pub-id pub-id-type="pmid">24744755</pub-id></mixed-citation></ref><ref id="B27"><label>27</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schlitzer</surname><given-names>A</given-names></name><name><surname>McGovern</surname><given-names>N</given-names></name><name><surname>Teo</surname><given-names>P</given-names></name><name><surname>Zelante</surname><given-names>T</given-names></name><name><surname>Atarashi</surname><given-names>K</given-names></name><name><surname>Low</surname><given-names>D</given-names></name><etal/></person-group>
<article-title>IRF4 transcription factor-dependent CD11b(+) dendritic cells in human and mouse control mucosal IL-17 cytokine responses</article-title>. <source>Immunity</source> (<year>2013</year>) <volume>38</volume>(<issue>5</issue>):<fpage>970</fpage>&#x02013;<lpage>83</lpage>.<pub-id pub-id-type="doi">10.1016/j.immuni.2013.04.011</pub-id><pub-id pub-id-type="pmid">23706669</pub-id></mixed-citation></ref><ref id="B28"><label>28</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Condon</surname><given-names>TV</given-names></name><name><surname>Sawyer</surname><given-names>RT</given-names></name><name><surname>Fenton</surname><given-names>MJ</given-names></name><name><surname>Riches</surname><given-names>DW</given-names></name></person-group>. <article-title>Lung dendritic cells at the innate-adaptive immune interface</article-title>. <source>J Leukoc Biol</source> (<year>2011</year>) <volume>90</volume>(<issue>5</issue>):<fpage>883</fpage>&#x02013;<lpage>95</lpage>.<pub-id pub-id-type="doi">10.1189/jlb.0311134</pub-id><?supplied-pmid 21807741?><pub-id pub-id-type="pmid">21807741</pub-id></mixed-citation></ref><ref id="B29"><label>29</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gehrie</surname><given-names>E</given-names></name><name><surname>Van der Touw</surname><given-names>W</given-names></name><name><surname>Bromberg</surname><given-names>JS</given-names></name><name><surname>Ochando</surname><given-names>JC</given-names></name></person-group>. <article-title>Plasmacytoid dendritic cells in tolerance</article-title>. <source>Methods Mol Biol</source> (<year>2011</year>) <volume>677</volume>:<fpage>127</fpage>&#x02013;<lpage>47</lpage>.<pub-id pub-id-type="doi">10.1007/978-1-60761-869-0_9</pub-id><?supplied-pmid 20941607?><pub-id pub-id-type="pmid">20941607</pub-id></mixed-citation></ref><ref id="B30"><label>30</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reizis</surname><given-names>B</given-names></name><name><surname>Bunin</surname><given-names>A</given-names></name><name><surname>Ghosh</surname><given-names>HS</given-names></name><name><surname>Lewis</surname><given-names>KL</given-names></name><name><surname>Sisirak</surname><given-names>V</given-names></name></person-group>. <article-title>Plasmacytoid dendritic cells: recent progress and open questions</article-title>. <source>Annu Rev Immunol</source> (<year>2011</year>) <volume>29</volume>:<fpage>163</fpage>&#x02013;<lpage>83</lpage>.<pub-id pub-id-type="doi">10.1146/annurev-immunol-031210-101345</pub-id><?supplied-pmid 21219184?><pub-id pub-id-type="pmid">21219184</pub-id></mixed-citation></ref><ref id="B31"><label>31</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Swiecki</surname><given-names>M</given-names></name><name><surname>Colonna</surname><given-names>M</given-names></name></person-group>. <article-title>The multifaceted biology of plasmacytoid dendritic cells</article-title>. <source>Nat Rev Immunol</source> (<year>2015</year>) <volume>15</volume>(<issue>8</issue>):<fpage>471</fpage>&#x02013;<lpage>85</lpage>.<pub-id pub-id-type="doi">10.1038/nri3865</pub-id><?supplied-pmid 26160613?><pub-id pub-id-type="pmid">26160613</pub-id></mixed-citation></ref><ref id="B32"><label>32</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Calvo</surname><given-names>C</given-names></name><name><surname>Garcia-Garcia</surname><given-names>ML</given-names></name><name><surname>Blanco</surname><given-names>C</given-names></name><name><surname>Vazquez</surname><given-names>MC</given-names></name><name><surname>Frias</surname><given-names>ME</given-names></name><name><surname>Perez-Brena</surname><given-names>P</given-names></name><etal/></person-group>
<article-title>Multiple simultaneous viral infections in infants with acute respiratory tract infections in Spain</article-title>. <source>J Clin Virol</source> (<year>2008</year>) <volume>42</volume>(<issue>3</issue>):<fpage>268</fpage>&#x02013;<lpage>72</lpage>.<pub-id pub-id-type="doi">10.1016/j.jcv.2008.03.012</pub-id><?supplied-pmid 18455958?><pub-id pub-id-type="pmid">18455958</pub-id></mixed-citation></ref><ref id="B33"><label>33</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bohmwald</surname><given-names>K</given-names></name><name><surname>Espinoza</surname><given-names>JA</given-names></name><name><surname>Rey-Jurado</surname><given-names>E</given-names></name><name><surname>Gomez</surname><given-names>RS</given-names></name><name><surname>Gonzalez</surname><given-names>PA</given-names></name><name><surname>Bueno</surname><given-names>SM</given-names></name><etal/></person-group>
<article-title>Human respiratory syncytial virus: infection and pathology</article-title>. <source>Semin Respir Crit Care Med</source> (<year>2016</year>) <volume>37</volume>(<issue>4</issue>):<fpage>522</fpage>&#x02013;<lpage>37</lpage>.<pub-id pub-id-type="doi">10.1055/s-0036-1584799</pub-id><pub-id pub-id-type="pmid">27486734</pub-id></mixed-citation></ref><ref id="B34"><label>34</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bueno</surname><given-names>SM</given-names></name><name><surname>Gonzalez</surname><given-names>PA</given-names></name><name><surname>Pacheco</surname><given-names>R</given-names></name><name><surname>Leiva</surname><given-names>ED</given-names></name><name><surname>Cautivo</surname><given-names>KM</given-names></name><name><surname>Tobar</surname><given-names>HE</given-names></name><etal/></person-group>
<article-title>Host immunity during RSV pathogenesis</article-title>. <source>Int Immunopharmacol</source> (<year>2008</year>) <volume>8</volume>(<issue>10</issue>):<fpage>1320</fpage>&#x02013;<lpage>9</lpage>.<pub-id pub-id-type="doi">10.1016/j.intimp.2008.03.012</pub-id><?supplied-pmid 18687294?><pub-id pub-id-type="pmid">18687294</pub-id></mixed-citation></ref><ref id="B35"><label>35</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Espinoza</surname><given-names>JA</given-names></name><name><surname>Bohmwald</surname><given-names>K</given-names></name><name><surname>Cespedes</surname><given-names>PF</given-names></name><name><surname>Riedel</surname><given-names>CA</given-names></name><name><surname>Bueno</surname><given-names>SM</given-names></name><name><surname>Kalergis</surname><given-names>AM</given-names></name></person-group>. <article-title>Modulation of host adaptive immunity by hRSV proteins</article-title>. <source>Virulence</source> (<year>2014</year>) <volume>5</volume>(<issue>7</issue>):<fpage>740</fpage>&#x02013;<lpage>51</lpage>.<pub-id pub-id-type="doi">10.4161/viru.32225</pub-id><?supplied-pmid 25513775?><pub-id pub-id-type="pmid">25513775</pub-id></mixed-citation></ref><ref id="B36"><label>36</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bohmwald</surname><given-names>K</given-names></name><name><surname>Espinoza</surname><given-names>JA</given-names></name><name><surname>Becerra</surname><given-names>D</given-names></name><name><surname>Rivera</surname><given-names>K</given-names></name><name><surname>Lay</surname><given-names>MK</given-names></name><name><surname>Bueno</surname><given-names>SM</given-names></name><etal/></person-group>
<article-title>Inflammatory damage on respiratory and nervous systems due to hRSV infection</article-title>. <source>Curr Opin Immunol</source> (<year>2015</year>) <volume>36</volume>:<fpage>14</fpage>&#x02013;<lpage>21</lpage>.<pub-id pub-id-type="doi">10.1016/j.coi.2015.05.003</pub-id><?supplied-pmid 26026788?><pub-id pub-id-type="pmid">26026788</pub-id></mixed-citation></ref><ref id="B37"><label>37</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ahout</surname><given-names>IM</given-names></name><name><surname>Jans</surname><given-names>J</given-names></name><name><surname>Haroutiounian</surname><given-names>L</given-names></name><name><surname>Simonetti</surname><given-names>ER</given-names></name><name><surname>van der Gaast-de Jongh</surname><given-names>C</given-names></name><name><surname>Diavatopoulos</surname><given-names>DA</given-names></name><etal/></person-group>
<article-title>Reduced expression of HLA-DR on monocytes during severe respiratory syncytial virus infections</article-title>. <source>Pediatr Infect Dis J</source> (<year>2016</year>) <volume>35</volume>(<issue>3</issue>):<fpage>e89</fpage>&#x02013;<lpage>96</lpage>.<pub-id pub-id-type="doi">10.1097/INF.0000000000001007</pub-id><?supplied-pmid 26658377?><pub-id pub-id-type="pmid">26658377</pub-id></mixed-citation></ref><ref id="B38"><label>38</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sweetman</surname><given-names>LL</given-names></name><name><surname>Ng</surname><given-names>YT</given-names></name><name><surname>Butler</surname><given-names>IJ</given-names></name><name><surname>Bodensteiner</surname><given-names>JB</given-names></name></person-group>. <article-title>Neurologic complications associated with respiratory syncytial virus</article-title>. <source>Pediatr Neurol</source> (<year>2005</year>) <volume>32</volume>(<issue>5</issue>):<fpage>307</fpage>&#x02013;<lpage>10</lpage>.<pub-id pub-id-type="doi">10.1016/j.pediatrneurol.2005.01.010</pub-id><?supplied-pmid 15866430?><pub-id pub-id-type="pmid">15866430</pub-id></mixed-citation></ref><ref id="B39"><label>39</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van Drunen Littel-van den Hurk</surname><given-names>S</given-names></name><name><surname>Watkiss</surname><given-names>ER</given-names></name></person-group>. <article-title>Pathogenesis of respiratory syncytial virus</article-title>. <source>Curr Opin Virol</source> (<year>2012</year>) <volume>2</volume>(<issue>3</issue>):<fpage>300</fpage>&#x02013;<lpage>5</lpage>.<pub-id pub-id-type="doi">10.1016/j.coviro.2012.01.008</pub-id><?supplied-pmid 22709517?><pub-id pub-id-type="pmid">22709517</pub-id></mixed-citation></ref><ref id="B40"><label>40</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Navas</surname><given-names>L</given-names></name><name><surname>Wang</surname><given-names>E</given-names></name><name><surname>de Carvalho</surname><given-names>V</given-names></name><name><surname>Robinson</surname><given-names>J</given-names></name></person-group>. <article-title>Improved outcome of respiratory syncytial virus infection in a high-risk hospitalized population of Canadian children. Pediatric investigators collaborative network on infections in Canada</article-title>. <source>J Pediatr</source> (<year>1992</year>) <volume>121</volume>(<issue>3</issue>):<fpage>348</fpage>&#x02013;<lpage>54</lpage>.<pub-id pub-id-type="doi">10.1016/S0022-3476(05)90000-0</pub-id><?supplied-pmid 1517907?><pub-id pub-id-type="pmid">1517907</pub-id></mixed-citation></ref><ref id="B41"><label>41</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>EE</given-names></name><name><surname>Law</surname><given-names>BJ</given-names></name><name><surname>Boucher</surname><given-names>FD</given-names></name><name><surname>Stephens</surname><given-names>D</given-names></name><name><surname>Robinson</surname><given-names>JL</given-names></name><name><surname>Dobson</surname><given-names>S</given-names></name><etal/></person-group>
<article-title>Pediatric Investigators Collaborative Network on Infections in Canada (PICNIC) study of admission and management variation in patients hospitalized with respiratory syncytial viral lower respiratory tract infection</article-title>. <source>J Pediatr</source> (<year>1996</year>) <volume>129</volume>(<issue>3</issue>):<fpage>390</fpage>&#x02013;<lpage>5</lpage>.<pub-id pub-id-type="doi">10.1016/S0022-3476(96)70071-9</pub-id><?supplied-pmid 8804328?><pub-id pub-id-type="pmid">8804328</pub-id></mixed-citation></ref><ref id="B42"><label>42</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boyce</surname><given-names>TG</given-names></name><name><surname>Mellen</surname><given-names>BG</given-names></name><name><surname>Mitchel</surname><given-names>EF</given-names><suffix>Jr</suffix></name><name><surname>Wright</surname><given-names>PF</given-names></name><name><surname>Griffin</surname><given-names>MR</given-names></name></person-group>. <article-title>Rates of hospitalization for respiratory syncytial virus infection among children in medicaid</article-title>. <source>J Pediatr</source> (<year>2000</year>) <volume>137</volume>(<issue>6</issue>):<fpage>865</fpage>&#x02013;<lpage>70</lpage>.<pub-id pub-id-type="doi">10.1067/mpd.2000.110531</pub-id><?supplied-pmid 11113845?><pub-id pub-id-type="pmid">11113845</pub-id></mixed-citation></ref><ref id="B43"><label>43</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aujard</surname><given-names>Y</given-names></name><name><surname>Fauroux</surname><given-names>B</given-names></name></person-group>
<article-title>Risk factors for severe respiratory syncytial virus infection in infants</article-title>. <source>Respir Med</source> (<year>2002</year>) <volume>96</volume>(<issue>Suppl B</issue>):<fpage>S9</fpage>&#x02013;<lpage>14</lpage>.<pub-id pub-id-type="doi">10.1053/rmed.2002.1295</pub-id></mixed-citation></ref><ref id="B44"><label>44</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Collins</surname><given-names>PL</given-names></name><name><surname>Graham</surname><given-names>BS</given-names></name></person-group>
<article-title>Viral and host factors in human respiratory syncytial virus pathogenesis</article-title>. <source>J Virol</source> (<year>2008</year>) <volume>82</volume>(<issue>5</issue>):<fpage>2040</fpage>&#x02013;<lpage>55</lpage>.<pub-id pub-id-type="doi">10.1128/JVI.01625-07</pub-id><pub-id pub-id-type="pmid">17928346</pub-id></mixed-citation></ref><ref id="B45"><label>45</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shi</surname><given-names>T</given-names></name><name><surname>McAllister</surname><given-names>DA</given-names></name><name><surname>O&#x02019;Brien</surname><given-names>KL</given-names></name><name><surname>Simoes</surname><given-names>EAF</given-names></name><name><surname>Madhi</surname><given-names>SA</given-names></name><name><surname>Gessner</surname><given-names>BD</given-names></name><etal/></person-group>
<article-title>Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in young children in 2015: a systematic review and modelling study</article-title>. <source>Lancet</source> (<year>2017</year>) <volume>390</volume>(<issue>10098</issue>):<fpage>946</fpage>&#x02013;<lpage>58</lpage>.<pub-id pub-id-type="doi">10.1016/S0140-6736(17)30938-8</pub-id><?supplied-pmid 28689664?><pub-id pub-id-type="pmid">28689664</pub-id></mixed-citation></ref><ref id="B46"><label>46</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nair</surname><given-names>H</given-names></name><name><surname>Simoes</surname><given-names>EA</given-names></name><name><surname>Rudan</surname><given-names>I</given-names></name><name><surname>Gessner</surname><given-names>BD</given-names></name><name><surname>Azziz-Baumgartner</surname><given-names>E</given-names></name><name><surname>Zhang</surname><given-names>JS</given-names></name><etal/></person-group>
<article-title>Global and regional burden of hospital admissions for severe acute lower respiratory infections in young children in 2010: a systematic analysis</article-title>. <source>Lancet</source> (<year>2013</year>) <volume>381</volume>(<issue>9875</issue>):<fpage>1380</fpage>&#x02013;<lpage>90</lpage>.<pub-id pub-id-type="doi">10.1016/S0140-6736(12)61901-1</pub-id><?supplied-pmid 23369797?><pub-id pub-id-type="pmid">23369797</pub-id></mixed-citation></ref><ref id="B47"><label>47</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Paramore</surname><given-names>LC</given-names></name><name><surname>Ciuryla</surname><given-names>V</given-names></name><name><surname>Ciesla</surname><given-names>G</given-names></name><name><surname>Liu</surname><given-names>L</given-names></name></person-group>. <article-title>Economic impact of respiratory syncytial virus-related illness in the US: an analysis of national databases</article-title>. <source>Pharmacoeconomics</source> (<year>2004</year>) <volume>22</volume>(<issue>5</issue>):<fpage>275</fpage>&#x02013;<lpage>84</lpage>.<pub-id pub-id-type="doi">10.2165/00019053-200422050-00001</pub-id><?supplied-pmid 15061677?><pub-id pub-id-type="pmid">15061677</pub-id></mixed-citation></ref><ref id="B48"><label>48</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dudas</surname><given-names>RA</given-names></name><name><surname>Karron</surname><given-names>RA</given-names></name></person-group>. <article-title>Respiratory syncytial virus vaccines</article-title>. <source>Clin Microbiol Rev</source> (<year>1998</year>) <volume>11</volume>(<issue>3</issue>):<fpage>430</fpage>&#x02013;<lpage>9</lpage>.<?supplied-pmid 9665976?><pub-id pub-id-type="pmid">9665976</pub-id></mixed-citation></ref><ref id="B49"><label>49</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Storey</surname><given-names>S</given-names></name></person-group>
<article-title>Respiratory syncytial virus market</article-title>. <source>Nat Rev Drug Discov</source> (<year>2010</year>) <volume>9</volume>(<issue>1</issue>):<fpage>15</fpage>&#x02013;<lpage>6</lpage>.<pub-id pub-id-type="doi">10.1038/nrd3075</pub-id><pub-id pub-id-type="pmid">20043025</pub-id></mixed-citation></ref><ref id="B50"><label>50</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gonzalez</surname><given-names>PA</given-names></name><name><surname>Prado</surname><given-names>CE</given-names></name><name><surname>Leiva</surname><given-names>ED</given-names></name><name><surname>Carreno</surname><given-names>LJ</given-names></name><name><surname>Bueno</surname><given-names>SM</given-names></name><name><surname>Riedel</surname><given-names>CA</given-names></name><etal/></person-group>
<article-title>Respiratory syncytial virus impairs T cell activation by preventing synapse assembly with dendritic cells</article-title>. <source>Proc Natl Acad Sci U S A</source> (<year>2008</year>) <volume>105</volume>(<issue>39</issue>):<fpage>14999</fpage>&#x02013;<lpage>5004</lpage>.<pub-id pub-id-type="doi">10.1073/pnas.0802555105</pub-id><?supplied-pmid 18818306?><pub-id pub-id-type="pmid">18818306</pub-id></mixed-citation></ref><ref id="B51"><label>51</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rossi</surname><given-names>GA</given-names></name><name><surname>Colin</surname><given-names>AA</given-names></name></person-group>. <article-title>Respiratory syncytial virus-Host interaction in the pathogenesis of bronchiolitis and its impact on respiratory morbidity in later life</article-title>. <source>Pediatr Allergy Immunol</source> (<year>2017</year>) <volume>28</volume>(<issue>4</issue>):<fpage>320</fpage>&#x02013;<lpage>31</lpage>.<pub-id pub-id-type="doi">10.1111/pai.12716</pub-id><?supplied-pmid 28339145?><pub-id pub-id-type="pmid">28339145</pub-id></mixed-citation></ref><ref id="B52"><label>52</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pickles</surname><given-names>RJ</given-names></name><name><surname>DeVincenzo</surname><given-names>JP</given-names></name></person-group>. <article-title>Respiratory syncytial virus (RSV) and its propensity for causing bronchiolitis</article-title>. <source>J Pathol</source> (<year>2015</year>) <volume>235</volume>(<issue>2</issue>):<fpage>266</fpage>&#x02013;<lpage>76</lpage>.<pub-id pub-id-type="doi">10.1002/path.4462</pub-id><?supplied-pmid 25302625?><pub-id pub-id-type="pmid">25302625</pub-id></mixed-citation></ref><ref id="B53"><label>53</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guo-Parke</surname><given-names>H</given-names></name><name><surname>Canning</surname><given-names>P</given-names></name><name><surname>Douglas</surname><given-names>I</given-names></name><name><surname>Villenave</surname><given-names>R</given-names></name><name><surname>Heaney</surname><given-names>LG</given-names></name><name><surname>Coyle</surname><given-names>PV</given-names></name><etal/></person-group>
<article-title>Relative respiratory syncytial virus cytopathogenesis in upper and lower respiratory tract epithelium</article-title>. <source>Am J Respir Crit Care Med</source> (<year>2013</year>) <volume>188</volume>(<issue>7</issue>):<fpage>842</fpage>&#x02013;<lpage>51</lpage>.<pub-id pub-id-type="doi">10.1164/rccm.201304-0750OC</pub-id><?supplied-pmid 23952745?><pub-id pub-id-type="pmid">23952745</pub-id></mixed-citation></ref><ref id="B54"><label>54</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barreira</surname><given-names>ER</given-names></name><name><surname>Precioso</surname><given-names>AR</given-names></name><name><surname>Bousso</surname><given-names>A</given-names></name></person-group>. <article-title>Pulmonary surfactant in respiratory syncytial virus bronchiolitis: the role in pathogenesis and clinical implications</article-title>. <source>Pediatr Pulmonol</source> (<year>2011</year>) <volume>46</volume>(<issue>5</issue>):<fpage>415</fpage>&#x02013;<lpage>20</lpage>.<pub-id pub-id-type="doi">10.1002/ppul.21395</pub-id><?supplied-pmid 21194166?><pub-id pub-id-type="pmid">21194166</pub-id></mixed-citation></ref><ref id="B55"><label>55</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Newton</surname><given-names>AH</given-names></name><name><surname>Cardani</surname><given-names>A</given-names></name><name><surname>Braciale</surname><given-names>TJ</given-names></name></person-group>
<article-title>The host immune response in respiratory virus infection: balancing virus clearance and immunopathology</article-title>. <source>Semin Immunopathol</source> (<year>2016</year>) <volume>38</volume>(<issue>4</issue>):<fpage>471</fpage>&#x02013;<lpage>82</lpage>.<pub-id pub-id-type="doi">10.1007/s00281-016-0558-0</pub-id><pub-id pub-id-type="pmid">26965109</pub-id></mixed-citation></ref><ref id="B56"><label>56</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Randolph</surname><given-names>GJ</given-names></name><name><surname>Jakubzick</surname><given-names>C</given-names></name><name><surname>Qu</surname><given-names>C</given-names></name></person-group>. <article-title>Antigen presentation by monocytes and monocyte-derived cells</article-title>. <source>Curr Opin Immunol</source> (<year>2008</year>) <volume>20</volume>(<issue>1</issue>):<fpage>52</fpage>&#x02013;<lpage>60</lpage>.<pub-id pub-id-type="doi">10.1016/j.coi.2007.10.010</pub-id><?supplied-pmid 18160272?><pub-id pub-id-type="pmid">18160272</pub-id></mixed-citation></ref><ref id="B57"><label>57</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cherrie</surname><given-names>AH</given-names></name><name><surname>Anderson</surname><given-names>K</given-names></name><name><surname>Wertz</surname><given-names>GW</given-names></name><name><surname>Openshaw</surname><given-names>PJ</given-names></name></person-group>. <article-title>Human cytotoxic T cells stimulated by antigen on dendritic cells recognize the N, SH, F, M, 22K, and 1b proteins of respiratory syncytial virus</article-title>. <source>J Virol</source> (<year>1992</year>) <volume>66</volume>(<issue>4</issue>):<fpage>2102</fpage>&#x02013;<lpage>10</lpage>.<?supplied-pmid 1548754?><pub-id pub-id-type="pmid">1548754</pub-id></mixed-citation></ref><ref id="B58"><label>58</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Werling</surname><given-names>D</given-names></name><name><surname>Hope</surname><given-names>JC</given-names></name><name><surname>Chaplin</surname><given-names>P</given-names></name><name><surname>Collins</surname><given-names>RA</given-names></name><name><surname>Taylor</surname><given-names>G</given-names></name><name><surname>Howard</surname><given-names>CJ</given-names></name></person-group>. <article-title>Involvement of caveolae in the uptake of respiratory syncytial virus antigen by dendritic cells</article-title>. <source>J Leukoc Biol</source> (<year>1999</year>) <volume>66</volume>(<issue>1</issue>):<fpage>50</fpage>&#x02013;<lpage>8</lpage>.<?supplied-pmid 10410989?><pub-id pub-id-type="pmid">10410989</pub-id></mixed-citation></ref><ref id="B59"><label>59</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Masten</surname><given-names>BJ</given-names></name><name><surname>Lipscomb</surname><given-names>MF</given-names></name></person-group>. <article-title>Dendritic cells: pulmonary immune regulation and asthma</article-title>. <source>Monaldi Arch Chest Dis</source> (<year>2000</year>) <volume>55</volume>(<issue>3</issue>):<fpage>225</fpage>&#x02013;<lpage>30</lpage>.<?supplied-pmid 10948671?><pub-id pub-id-type="pmid">10948671</pub-id></mixed-citation></ref><ref id="B60"><label>60</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Becker</surname><given-names>S</given-names></name><name><surname>Soukup</surname><given-names>JM</given-names></name></person-group>. <article-title>Airway epithelial cell-induced activation of monocytes and eosinophils in respiratory syncytial viral infection</article-title>. <source>Immunobiology</source> (<year>1999</year>) <volume>201</volume>(<issue>1</issue>):<fpage>88</fpage>&#x02013;<lpage>106</lpage>.<pub-id pub-id-type="doi">10.1016/S0171-2985(99)80049-7</pub-id><?supplied-pmid 10532283?><pub-id pub-id-type="pmid">10532283</pub-id></mixed-citation></ref><ref id="B61"><label>61</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Soukup</surname><given-names>JM</given-names></name><name><surname>Becker</surname><given-names>S</given-names></name></person-group>. <article-title>Role of monocytes and eosinophils in human respiratory syncytial virus infection in vitro</article-title>. <source>Clin Immunol</source> (<year>2003</year>) <volume>107</volume>(<issue>3</issue>):<fpage>178</fpage>&#x02013;<lpage>85</lpage>.<pub-id pub-id-type="doi">10.1016/S1521-6616(03)00038-X</pub-id><?supplied-pmid 12804531?><pub-id pub-id-type="pmid">12804531</pub-id></mixed-citation></ref><ref id="B62"><label>62</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oumouna</surname><given-names>M</given-names></name><name><surname>Weitnauer</surname><given-names>M</given-names></name><name><surname>Mijosek</surname><given-names>V</given-names></name><name><surname>Schmidt</surname><given-names>LM</given-names></name><name><surname>Eigenbrod</surname><given-names>T</given-names></name><name><surname>Dalpke</surname><given-names>AH</given-names></name></person-group>. <article-title>Cell-contact dependent inhibition of monocytes by airway epithelial cells and reversion by infection with respiratory syncytial virus</article-title>. <source>Immunobiology</source> (<year>2015</year>) <volume>220</volume>(<issue>11</issue>):<fpage>1240</fpage>&#x02013;<lpage>5</lpage>.<pub-id pub-id-type="doi">10.1016/j.imbio.2015.06.017</pub-id><?supplied-pmid 26153873?><pub-id pub-id-type="pmid">26153873</pub-id></mixed-citation></ref><ref id="B63"><label>63</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Salkind</surname><given-names>AR</given-names></name><name><surname>Nichols</surname><given-names>JE</given-names></name><name><surname>Roberts</surname><given-names>NJ</given-names><suffix>Jr</suffix></name></person-group>. <article-title>Suppressed expression of ICAM-1 and LFA-1 and abrogation of leukocyte collaboration after exposure of human mononuclear leukocytes to respiratory syncytial virus in vitro. Comparison with exposure to influenza virus</article-title>. <source>J Clin Invest</source> (<year>1991</year>) <volume>88</volume>(<issue>2</issue>):<fpage>505</fpage>&#x02013;<lpage>11</lpage>.<pub-id pub-id-type="doi">10.1172/JCI115332</pub-id><?supplied-pmid 1677945?><pub-id pub-id-type="pmid">1677945</pub-id></mixed-citation></ref><ref id="B64"><label>64</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maus</surname><given-names>U</given-names></name><name><surname>Herold</surname><given-names>S</given-names></name><name><surname>Muth</surname><given-names>H</given-names></name><name><surname>Maus</surname><given-names>R</given-names></name><name><surname>Ermert</surname><given-names>L</given-names></name><name><surname>Ermert</surname><given-names>M</given-names></name><etal/></person-group>
<article-title>Monocytes recruited into the alveolar air space of mice show a monocytic phenotype but upregulate CD14</article-title>. <source>Am J Physiol Lung Cell Mol Physiol</source> (<year>2001</year>) <volume>280</volume>(<issue>1</issue>):<fpage>L58</fpage>&#x02013;<lpage>68</lpage>.<?supplied-pmid 11133495?><pub-id pub-id-type="pmid">11133495</pub-id></mixed-citation></ref><ref id="B65"><label>65</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maus</surname><given-names>UA</given-names></name><name><surname>Janzen</surname><given-names>S</given-names></name><name><surname>Wall</surname><given-names>G</given-names></name><name><surname>Srivastava</surname><given-names>M</given-names></name><name><surname>Blackwell</surname><given-names>TS</given-names></name><name><surname>Christman</surname><given-names>JW</given-names></name><etal/></person-group>
<article-title>Resident alveolar macrophages are replaced by recruited monocytes in response to endotoxin-induced lung inflammation</article-title>. <source>Am J Respir Cell Mol Biol</source> (<year>2006</year>) <volume>35</volume>(<issue>2</issue>):<fpage>227</fpage>&#x02013;<lpage>35</lpage>.<pub-id pub-id-type="doi">10.1165/rcmb.2005-0241OC</pub-id><?supplied-pmid 16543608?><pub-id pub-id-type="pmid">16543608</pub-id></mixed-citation></ref><ref id="B66"><label>66</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Collins</surname><given-names>CL</given-names></name><name><surname>Pollard</surname><given-names>AJ</given-names></name></person-group>. <article-title>Respiratory syncytial virus infections in children and adults</article-title>. <source>J Infect</source> (<year>2002</year>) <volume>45</volume>(<issue>1</issue>):<fpage>10</fpage>&#x02013;<lpage>7</lpage>.<pub-id pub-id-type="doi">10.1053/jinf.2001.1016</pub-id><?supplied-pmid 12217725?><pub-id pub-id-type="pmid">12217725</pub-id></mixed-citation></ref><ref id="B67"><label>67</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bont</surname><given-names>L</given-names></name><name><surname>Heijnen</surname><given-names>CJ</given-names></name><name><surname>Kavelaars</surname><given-names>A</given-names></name><name><surname>van Aalderen</surname><given-names>WM</given-names></name><name><surname>Brus</surname><given-names>F</given-names></name><name><surname>Draaisma</surname><given-names>JT</given-names></name><etal/></person-group>
<article-title>Monocyte IL-10 production during respiratory syncytial virus bronchiolitis is associated with recurrent wheezing in a one-year follow-up study</article-title>. <source>Am J Respir Crit Care Med</source> (<year>2000</year>) <volume>161</volume>(<issue>5</issue>):<fpage>1518</fpage>&#x02013;<lpage>23</lpage>.<pub-id pub-id-type="doi">10.1164/ajrccm.161.5.9904078</pub-id><?supplied-pmid 10806148?><pub-id pub-id-type="pmid">10806148</pub-id></mixed-citation></ref><ref id="B68"><label>68</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bendelja</surname><given-names>K</given-names></name><name><surname>Vojvoda</surname><given-names>V</given-names></name><name><surname>Aberle</surname><given-names>N</given-names></name><name><surname>Cepin-Bogovic</surname><given-names>J</given-names></name><name><surname>Gagro</surname><given-names>A</given-names></name><name><surname>Mlinaric-Galinovic</surname><given-names>G</given-names></name><etal/></person-group>
<article-title>Decreased toll-like receptor 8 expression and lower TNF-alpha synthesis in infants with acute RSV infection</article-title>. <source>Respir Res</source> (<year>2010</year>) <volume>11</volume>:<fpage>143</fpage><pub-id pub-id-type="doi">10.1186/1465-9921-11-143</pub-id><pub-id pub-id-type="pmid">20946625</pub-id></mixed-citation></ref><ref id="B69"><label>69</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Byrne</surname><given-names>AJ</given-names></name><name><surname>Maher</surname><given-names>TM</given-names></name><name><surname>Lloyd</surname><given-names>CM</given-names></name></person-group>. <article-title>Pulmonary macrophages: a new therapeutic pathway in fibrosing lung disease?</article-title>
<source>Trends Mol Med</source> (<year>2016</year>) <volume>22</volume>(<issue>4</issue>):<fpage>303</fpage>&#x02013;<lpage>16</lpage>.<pub-id pub-id-type="doi">10.1016/j.molmed.2016.02.004</pub-id><?supplied-pmid 26979628?><pub-id pub-id-type="pmid">26979628</pub-id></mixed-citation></ref><ref id="B70"><label>70</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kolli</surname><given-names>D</given-names></name><name><surname>Gupta</surname><given-names>MR</given-names></name><name><surname>Sbrana</surname><given-names>E</given-names></name><name><surname>Velayutham</surname><given-names>TS</given-names></name><name><surname>Chao</surname><given-names>H</given-names></name><name><surname>Casola</surname><given-names>A</given-names></name><etal/></person-group>
<article-title>Alveolar macrophages contribute to the pathogenesis of human metapneumovirus infection while protecting against respiratory syncytial virus infection</article-title>. <source>Am J Respir Cell Mol Biol</source> (<year>2014</year>) <volume>51</volume>(<issue>4</issue>):<fpage>502</fpage>&#x02013;<lpage>15</lpage>.<pub-id pub-id-type="doi">10.1165/rcmb.2013-0414OC</pub-id><?supplied-pmid 24749674?><pub-id pub-id-type="pmid">24749674</pub-id></mixed-citation></ref><ref id="B71"><label>71</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rivera</surname><given-names>R</given-names></name><name><surname>Hutchens</surname><given-names>M</given-names></name><name><surname>Luker</surname><given-names>KE</given-names></name><name><surname>Sonstein</surname><given-names>J</given-names></name><name><surname>Curtis</surname><given-names>JL</given-names></name><name><surname>Luker</surname><given-names>GD</given-names></name></person-group>. <article-title>Murine alveolar macrophages limit replication of vaccinia virus</article-title>. <source>Virology</source> (<year>2007</year>) <volume>363</volume>(<issue>1</issue>):<fpage>48</fpage>&#x02013;<lpage>58</lpage>.<pub-id pub-id-type="doi">10.1016/j.virol.2007.01.033</pub-id><?supplied-pmid 17331554?><pub-id pub-id-type="pmid">17331554</pub-id></mixed-citation></ref><ref id="B72"><label>72</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Blumenthal</surname><given-names>RL</given-names></name><name><surname>Campbell</surname><given-names>DE</given-names></name><name><surname>Hwang</surname><given-names>P</given-names></name><name><surname>DeKruyff</surname><given-names>RH</given-names></name><name><surname>Frankel</surname><given-names>LR</given-names></name><name><surname>Umetsu</surname><given-names>DT</given-names></name></person-group>. <article-title>Human alveolar macrophages induce functional inactivation in antigen-specific CD4 T cells</article-title>. <source>J Allergy Clin Immunol</source> (<year>2001</year>) <volume>107</volume>(<issue>2</issue>):<fpage>258</fpage>&#x02013;<lpage>64</lpage>.<pub-id pub-id-type="doi">10.1067/mai.2001.112845</pub-id><?supplied-pmid 11174191?><pub-id pub-id-type="pmid">11174191</pub-id></mixed-citation></ref><ref id="B73"><label>73</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Empey</surname><given-names>KM</given-names></name><name><surname>Orend</surname><given-names>JG</given-names></name><name><surname>Peebles</surname><given-names>RS</given-names><suffix>Jr</suffix></name><name><surname>Egana</surname><given-names>L</given-names></name><name><surname>Norris</surname><given-names>KA</given-names></name><name><surname>Oury</surname><given-names>TD</given-names></name><etal/></person-group>
<article-title>Stimulation of immature lung macrophages with intranasal interferon gamma in a novel neonatal mouse model of respiratory syncytial virus infection</article-title>. <source>PLoS One</source> (<year>2012</year>) <volume>7</volume>(<issue>7</issue>):<fpage>e40499</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0040499</pub-id><pub-id pub-id-type="pmid">22792355</pub-id></mixed-citation></ref><ref id="B74"><label>74</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Benoit</surname><given-names>A</given-names></name><name><surname>Huang</surname><given-names>Y</given-names></name><name><surname>Proctor</surname><given-names>J</given-names></name><name><surname>Rowden</surname><given-names>G</given-names></name><name><surname>Anderson</surname><given-names>R</given-names></name></person-group>. <article-title>Effects of alveolar macrophage depletion on liposomal vaccine protection against respiratory syncytial virus (RSV)</article-title>. <source>Clin Exp Immunol</source> (<year>2006</year>) <volume>145</volume>(<issue>1</issue>):<fpage>147</fpage>&#x02013;<lpage>54</lpage>.<pub-id pub-id-type="doi">10.1111/j.1365-2249.2006.03114.x</pub-id><?supplied-pmid 16792685?><pub-id pub-id-type="pmid">16792685</pub-id></mixed-citation></ref><ref id="B75"><label>75</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Makris</surname><given-names>S</given-names></name><name><surname>Bajorek</surname><given-names>M</given-names></name><name><surname>Culley</surname><given-names>FJ</given-names></name><name><surname>Goritzka</surname><given-names>M</given-names></name><name><surname>Johansson</surname><given-names>C</given-names></name></person-group>. <article-title>Alveolar macrophages can control respiratory syncytial virus infection in the absence of type I interferons</article-title>. <source>J Innate Immun</source> (<year>2016</year>) <volume>8</volume>(<issue>5</issue>):<fpage>452</fpage>&#x02013;<lpage>63</lpage>.<pub-id pub-id-type="doi">10.1159/000446824</pub-id><?supplied-pmid 27423203?><pub-id pub-id-type="pmid">27423203</pub-id></mixed-citation></ref><ref id="B76"><label>76</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reed</surname><given-names>JL</given-names></name><name><surname>Brewah</surname><given-names>YA</given-names></name><name><surname>Delaney</surname><given-names>T</given-names></name><name><surname>Welliver</surname><given-names>T</given-names></name><name><surname>Burwell</surname><given-names>T</given-names></name><name><surname>Benjamin</surname><given-names>E</given-names></name><etal/></person-group>
<article-title>Macrophage impairment underlies airway occlusion in primary respiratory syncytial virus bronchiolitis</article-title>. <source>J Infect Dis</source> (<year>2008</year>) <volume>198</volume>(<issue>12</issue>):<fpage>1783</fpage>&#x02013;<lpage>93</lpage>.<pub-id pub-id-type="doi">10.1086/593173</pub-id><?supplied-pmid 18980502?><pub-id pub-id-type="pmid">18980502</pub-id></mixed-citation></ref><ref id="B77"><label>77</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goritzka</surname><given-names>M</given-names></name><name><surname>Makris</surname><given-names>S</given-names></name><name><surname>Kausar</surname><given-names>F</given-names></name><name><surname>Durant</surname><given-names>LR</given-names></name><name><surname>Pereira</surname><given-names>C</given-names></name><name><surname>Kumagai</surname><given-names>Y</given-names></name><etal/></person-group>
<article-title>Alveolar macrophage-derived type I interferons orchestrate innate immunity to RSV through recruitment of antiviral monocytes</article-title>. <source>J Exp Med</source> (<year>2015</year>) <volume>212</volume>(<issue>5</issue>):<fpage>699</fpage>&#x02013;<lpage>714</lpage>.<pub-id pub-id-type="doi">10.1084/jem.20140825</pub-id><?supplied-pmid 25897172?><pub-id pub-id-type="pmid">25897172</pub-id></mixed-citation></ref><ref id="B78"><label>78</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Becker</surname><given-names>S</given-names></name><name><surname>Quay</surname><given-names>J</given-names></name><name><surname>Soukup</surname><given-names>J</given-names></name></person-group>. <article-title>Cytokine (tumor necrosis factor, IL-6, and IL-8) production by respiratory syncytial virus-infected human alveolar macrophages</article-title>. <source>J Immunol</source> (<year>1991</year>) <volume>147</volume>(<issue>12</issue>):<fpage>4307</fpage>&#x02013;<lpage>12</lpage>.<?supplied-pmid 1753101?><pub-id pub-id-type="pmid">1753101</pub-id></mixed-citation></ref><ref id="B79"><label>79</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Franke-Ullmann</surname><given-names>G</given-names></name><name><surname>Pfortner</surname><given-names>C</given-names></name><name><surname>Walter</surname><given-names>P</given-names></name><name><surname>Steinmuller</surname><given-names>C</given-names></name><name><surname>Lohmann-Matthes</surname><given-names>ML</given-names></name><name><surname>Kobzik</surname><given-names>L</given-names></name><etal/></person-group>
<article-title>Alteration of pulmonary macrophage function by respiratory syncytial virus infection in vitro</article-title>. <source>J Immunol</source> (<year>1995</year>) <volume>154</volume>(<issue>1</issue>):<fpage>268</fpage>&#x02013;<lpage>80</lpage>.<?supplied-pmid 7995946?><pub-id pub-id-type="pmid">7995946</pub-id></mixed-citation></ref><ref id="B80"><label>80</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Roberts</surname><given-names>NJ</given-names><suffix>Jr</suffix></name><name><surname>Prill</surname><given-names>AH</given-names></name><name><surname>Mann</surname><given-names>TN</given-names></name></person-group>. <article-title>Interleukin 1 and interleukin 1 inhibitor production by human macrophages exposed to influenza virus or respiratory syncytial virus. Respiratory syncytial virus is a potent inducer of inhibitor activity</article-title>. <source>J Exp Med</source> (<year>1986</year>) <volume>163</volume>(<issue>3</issue>):<fpage>511</fpage>&#x02013;<lpage>9</lpage>.<pub-id pub-id-type="doi">10.1084/jem.163.3.511</pub-id><?supplied-pmid 3485170?><pub-id pub-id-type="pmid">3485170</pub-id></mixed-citation></ref><ref id="B81"><label>81</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tsutsumi</surname><given-names>H</given-names></name><name><surname>Matsuda</surname><given-names>K</given-names></name><name><surname>Sone</surname><given-names>S</given-names></name><name><surname>Takeuchi</surname><given-names>R</given-names></name><name><surname>Chiba</surname><given-names>S</given-names></name></person-group>. <article-title>Respiratory syncytial virus-induced cytokine production by neonatal macrophages</article-title>. <source>Clin Exp Immunol</source> (<year>1996</year>) <volume>106</volume>(<issue>3</issue>):<fpage>442</fpage>&#x02013;<lpage>6</lpage>.<pub-id pub-id-type="doi">10.1046/j.1365-2249.1996.d01-874.x</pub-id><?supplied-pmid 8973610?><pub-id pub-id-type="pmid">8973610</pub-id></mixed-citation></ref><ref id="B82"><label>82</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Panuska</surname><given-names>JR</given-names></name><name><surname>Merolla</surname><given-names>R</given-names></name><name><surname>Rebert</surname><given-names>NA</given-names></name><name><surname>Hoffmann</surname><given-names>SP</given-names></name><name><surname>Tsivitse</surname><given-names>P</given-names></name><name><surname>Cirino</surname><given-names>NM</given-names></name><etal/></person-group>
<article-title>Respiratory syncytial virus induces interleukin-10 by human alveolar macrophages. Suppression of early cytokine production and implications for incomplete immunity</article-title>. <source>J Clin Invest</source> (<year>1995</year>) <volume>96</volume>(<issue>5</issue>):<fpage>2445</fpage>&#x02013;<lpage>53</lpage>.<pub-id pub-id-type="doi">10.1172/JCI118302</pub-id><?supplied-pmid 7593633?><pub-id pub-id-type="pmid">7593633</pub-id></mixed-citation></ref><ref id="B83"><label>83</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Haeberle</surname><given-names>HA</given-names></name><name><surname>Takizawa</surname><given-names>R</given-names></name><name><surname>Casola</surname><given-names>A</given-names></name><name><surname>Brasier</surname><given-names>AR</given-names></name><name><surname>Dieterich</surname><given-names>HJ</given-names></name><name><surname>Van Rooijen</surname><given-names>N</given-names></name><etal/></person-group>
<article-title>Respiratory syncytial virus-induced activation of nuclear factor-kappaB in the lung involves alveolar macrophages and toll-like receptor 4-dependent pathways</article-title>. <source>J Infect Dis</source> (<year>2002</year>) <volume>186</volume>(<issue>9</issue>):<fpage>1199</fpage>&#x02013;<lpage>206</lpage>.<pub-id pub-id-type="doi">10.1086/344644</pub-id><?supplied-pmid 12402188?><pub-id pub-id-type="pmid">12402188</pub-id></mixed-citation></ref><ref id="B84"><label>84</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Harris</surname><given-names>J</given-names></name><name><surname>Werling</surname><given-names>D</given-names></name></person-group>. <article-title>Binding and entry of respiratory syncytial virus into host cells and initiation of the innate immune response</article-title>. <source>Cell Microbiol</source> (<year>2003</year>) <volume>5</volume>(<issue>10</issue>):<fpage>671</fpage>&#x02013;<lpage>80</lpage>.<pub-id pub-id-type="doi">10.1046/j.1462-5822.2003.00313.x</pub-id><?supplied-pmid 12969373?><pub-id pub-id-type="pmid">12969373</pub-id></mixed-citation></ref><ref id="B85"><label>85</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Haynes</surname><given-names>LM</given-names></name><name><surname>Moore</surname><given-names>DD</given-names></name><name><surname>Kurt-Jones</surname><given-names>EA</given-names></name><name><surname>Finberg</surname><given-names>RW</given-names></name><name><surname>Anderson</surname><given-names>LJ</given-names></name><name><surname>Tripp</surname><given-names>RA</given-names></name></person-group>. <article-title>Involvement of toll-like receptor 4 in innate immunity to respiratory syncytial virus</article-title>. <source>J Virol</source> (<year>2001</year>) <volume>75</volume>(<issue>22</issue>):<fpage>10730</fpage>&#x02013;<lpage>7</lpage>.<pub-id pub-id-type="doi">10.1128/JVI.75.22.10730-10737.2001</pub-id><?supplied-pmid 11602714?><pub-id pub-id-type="pmid">11602714</pub-id></mixed-citation></ref><ref id="B86"><label>86</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schijf</surname><given-names>MA</given-names></name><name><surname>Lukens</surname><given-names>MV</given-names></name><name><surname>Kruijsen</surname><given-names>D</given-names></name><name><surname>van Uden</surname><given-names>NO</given-names></name><name><surname>Garssen</surname><given-names>J</given-names></name><name><surname>Coenjaerts</surname><given-names>FE</given-names></name><etal/></person-group>
<article-title>Respiratory syncytial virus induced type I IFN production by pDC is regulated by RSV-infected airway epithelial cells, RSV-exposed monocytes and virus specific antibodies</article-title>. <source>PLoS One</source> (<year>2013</year>) <volume>8</volume>(<issue>11</issue>):<fpage>e81695</fpage>.<pub-id pub-id-type="doi">10.1371/journal.pone.0081695</pub-id><?supplied-pmid 24303065?><pub-id pub-id-type="pmid">24303065</pub-id></mixed-citation></ref><ref id="B87"><label>87</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marr</surname><given-names>N</given-names></name><name><surname>Turvey</surname><given-names>SE</given-names></name></person-group>
<article-title>Role of human TLR4 in respiratory syncytial virus-induced NF-kappaB activation, viral entry and replication</article-title>. <source>Innate Immun</source> (<year>2012</year>) <volume>18</volume>(<issue>6</issue>):<fpage>856</fpage>&#x02013;<lpage>65</lpage>.<pub-id pub-id-type="doi">10.1177/1753425912444479</pub-id><pub-id pub-id-type="pmid">22535679</pub-id></mixed-citation></ref><ref id="B88"><label>88</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shirey</surname><given-names>KA</given-names></name><name><surname>Pletneva</surname><given-names>LM</given-names></name><name><surname>Puche</surname><given-names>AC</given-names></name><name><surname>Keegan</surname><given-names>AD</given-names></name><name><surname>Prince</surname><given-names>GA</given-names></name><name><surname>Blanco</surname><given-names>JC</given-names></name><etal/></person-group>
<article-title>Control of RSV-induced lung injury by alternatively activated macrophages is IL-4R alpha-, TLR4-, and IFN-beta-dependent</article-title>. <source>Mucosal Immunol</source> (<year>2010</year>) <volume>3</volume>(<issue>3</issue>):<fpage>291</fpage>&#x02013;<lpage>300</lpage>.<pub-id pub-id-type="doi">10.1038/mi.2010.6</pub-id><?supplied-pmid 20404812?><pub-id pub-id-type="pmid">20404812</pub-id></mixed-citation></ref><ref id="B89"><label>89</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schultz</surname><given-names>C</given-names></name><name><surname>Richter</surname><given-names>N</given-names></name><name><surname>Moller</surname><given-names>JC</given-names></name><name><surname>Bucsky</surname><given-names>P</given-names></name></person-group>
<article-title>IFN-gamma response and IL-8 plasma levels in neonates with respiratory syncytial virus bronchiolitis</article-title>. <source>Eur Respir J</source> (<year>2001</year>) <volume>17</volume>(<issue>2</issue>):<fpage>321</fpage>&#x02013;<lpage>4</lpage>.<pub-id pub-id-type="doi">10.1183/09031936.01.17203210</pub-id><pub-id pub-id-type="pmid">11334138</pub-id></mixed-citation></ref><ref id="B90"><label>90</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Harker</surname><given-names>JA</given-names></name><name><surname>Yamaguchi</surname><given-names>Y</given-names></name><name><surname>Culley</surname><given-names>FJ</given-names></name><name><surname>Tregoning</surname><given-names>JS</given-names></name><name><surname>Openshaw</surname><given-names>PJ</given-names></name></person-group>. <article-title>Delayed sequelae of neonatal respiratory syncytial virus infection are dependent on cells of the innate immune system</article-title>. <source>J Virol</source> (<year>2014</year>) <volume>88</volume>(<issue>1</issue>):<fpage>604</fpage>&#x02013;<lpage>11</lpage>.<pub-id pub-id-type="doi">10.1128/JVI.02620-13</pub-id><?supplied-pmid 24173217?><pub-id pub-id-type="pmid">24173217</pub-id></mixed-citation></ref><ref id="B91"><label>91</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eichinger</surname><given-names>KM</given-names></name><name><surname>Egana</surname><given-names>L</given-names></name><name><surname>Orend</surname><given-names>JG</given-names></name><name><surname>Resetar</surname><given-names>E</given-names></name><name><surname>Anderson</surname><given-names>KB</given-names></name><name><surname>Patel</surname><given-names>R</given-names></name><etal/></person-group>
<article-title>Alveolar macrophages support interferon gamma-mediated viral clearance in RSV-infected neonatal mice</article-title>. <source>Respir Res</source> (<year>2015</year>) <volume>16</volume>:<fpage>122</fpage>.<pub-id pub-id-type="doi">10.1186/s12931-015-0282-7</pub-id><?supplied-pmid 26438053?><pub-id pub-id-type="pmid">26438053</pub-id></mixed-citation></ref><ref id="B92"><label>92</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guilliams</surname><given-names>M</given-names></name><name><surname>Lambrecht</surname><given-names>BN</given-names></name><name><surname>Hammad</surname><given-names>H</given-names></name></person-group>. <article-title>Division of labor between lung dendritic cells and macrophages in the defense against pulmonary infections</article-title>. <source>Mucosal Immunol</source> (<year>2013</year>) <volume>6</volume>(<issue>3</issue>):<fpage>464</fpage>&#x02013;<lpage>73</lpage>.<pub-id pub-id-type="doi">10.1038/mi.2013.14</pub-id><?supplied-pmid 23549447?><pub-id pub-id-type="pmid">23549447</pub-id></mixed-citation></ref><ref id="B93"><label>93</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Qi</surname><given-names>F</given-names></name><name><surname>Wang</surname><given-names>D</given-names></name><name><surname>Liu</surname><given-names>J</given-names></name><name><surname>Zeng</surname><given-names>S</given-names></name><name><surname>Xu</surname><given-names>L</given-names></name><name><surname>Hu</surname><given-names>H</given-names></name><etal/></person-group>
<article-title>Respiratory macrophages and dendritic cells mediate respiratory syncytial virus-induced IL-33 production in TLR3- or TLR7-dependent manner</article-title>. <source>Int Immunopharmacol</source> (<year>2015</year>) <volume>29</volume>(<issue>2</issue>):<fpage>408</fpage>&#x02013;<lpage>15</lpage>.<pub-id pub-id-type="doi">10.1016/j.intimp.2015.10.022</pub-id><?supplied-pmid 26603638?><pub-id pub-id-type="pmid">26603638</pub-id></mixed-citation></ref><ref id="B94"><label>94</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Johnson</surname><given-names>TR</given-names></name><name><surname>Johnson</surname><given-names>CN</given-names></name><name><surname>Corbett</surname><given-names>KS</given-names></name><name><surname>Edwards</surname><given-names>GC</given-names></name><name><surname>Graham</surname><given-names>BS</given-names></name></person-group>. <article-title>Primary human mDC1, mDC2, and pDC dendritic cells are differentially infected and activated by respiratory syncytial virus</article-title>. <source>PLoS One</source> (<year>2011</year>) <volume>6</volume>(<issue>1</issue>):<fpage>e16458</fpage>.<pub-id pub-id-type="doi">10.1371/journal.pone.0016458</pub-id><?supplied-pmid 21297989?><pub-id pub-id-type="pmid">21297989</pub-id></mixed-citation></ref><ref id="B95"><label>95</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schwarze</surname><given-names>J</given-names></name></person-group>. <article-title>Lung dendritic cells in respiratory syncytial virus bronchiolitis</article-title>. <source>Pediatr Infect Dis J</source> (<year>2008</year>) <volume>27</volume>(<issue>10 Suppl</issue>):<fpage>S89</fpage>&#x02013;<lpage>91</lpage>.<pub-id pub-id-type="doi">10.1097/INF.0b013e318168b6f0</pub-id><?supplied-pmid 18820586?><pub-id pub-id-type="pmid">18820586</pub-id></mixed-citation></ref><ref id="B96"><label>96</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kondo</surname><given-names>Y</given-names></name><name><surname>Matsuse</surname><given-names>H</given-names></name><name><surname>Machida</surname><given-names>I</given-names></name><name><surname>Kawano</surname><given-names>T</given-names></name><name><surname>Saeki</surname><given-names>S</given-names></name><name><surname>Tomari</surname><given-names>S</given-names></name><etal/></person-group>
<article-title>Regulation of mite allergen-pulsed murine dendritic cells by respiratory syncytial virus</article-title>. <source>Am J Respir Crit Care Med</source> (<year>2004</year>) <volume>169</volume>(<issue>4</issue>):<fpage>494</fpage>&#x02013;<lpage>8</lpage>.<pub-id pub-id-type="doi">10.1164/rccm.200305-663OC</pub-id><?supplied-pmid 14656751?><pub-id pub-id-type="pmid">14656751</pub-id></mixed-citation></ref><ref id="B97"><label>97</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>de Graaff</surname><given-names>PM</given-names></name><name><surname>de Jong</surname><given-names>EC</given-names></name><name><surname>van Capel</surname><given-names>TM</given-names></name><name><surname>van Dijk</surname><given-names>ME</given-names></name><name><surname>Roholl</surname><given-names>PJ</given-names></name><name><surname>Boes</surname><given-names>J</given-names></name><etal/></person-group>
<article-title>Respiratory syncytial virus infection of monocyte-derived dendritic cells decreases their capacity to activate CD4 T cells</article-title>. <source>J Immunol</source> (<year>2005</year>) <volume>175</volume>(<issue>9</issue>):<fpage>5904</fpage>&#x02013;<lpage>11</lpage>.<pub-id pub-id-type="doi">10.4049/jimmunol.175.9.5904</pub-id><?supplied-pmid 16237083?><pub-id pub-id-type="pmid">16237083</pub-id></mixed-citation></ref><ref id="B98"><label>98</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guerrero-Plata</surname><given-names>A</given-names></name><name><surname>Casola</surname><given-names>A</given-names></name><name><surname>Suarez</surname><given-names>G</given-names></name><name><surname>Yu</surname><given-names>X</given-names></name><name><surname>Spetch</surname><given-names>L</given-names></name><name><surname>Peeples</surname><given-names>ME</given-names></name><etal/></person-group>
<article-title>Differential response of dendritic cells to human metapneumovirus and respiratory syncytial virus</article-title>. <source>Am J Respir Cell Mol Biol</source> (<year>2006</year>) <volume>34</volume>(<issue>3</issue>):<fpage>320</fpage>&#x02013;<lpage>9</lpage>.<pub-id pub-id-type="doi">10.1165/rcmb.2005-0287OC</pub-id><?supplied-pmid 16284360?><pub-id pub-id-type="pmid">16284360</pub-id></mixed-citation></ref><ref id="B99"><label>99</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kurt-Jones</surname><given-names>EA</given-names></name><name><surname>Popova</surname><given-names>L</given-names></name><name><surname>Kwinn</surname><given-names>L</given-names></name><name><surname>Haynes</surname><given-names>LM</given-names></name><name><surname>Jones</surname><given-names>LP</given-names></name><name><surname>Tripp</surname><given-names>RA</given-names></name><etal/></person-group>
<article-title>Pattern recognition receptors TLR4 and CD14 mediate response to respiratory syncytial virus</article-title>. <source>Nat Immunol</source> (<year>2000</year>) <volume>1</volume>(<issue>5</issue>):<fpage>398</fpage>&#x02013;<lpage>401</lpage>.<pub-id pub-id-type="doi">10.1038/80833</pub-id><?supplied-pmid 11062499?><pub-id pub-id-type="pmid">11062499</pub-id></mixed-citation></ref><ref id="B100"><label>100</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Murawski</surname><given-names>MR</given-names></name><name><surname>Bowen</surname><given-names>GN</given-names></name><name><surname>Cerny</surname><given-names>AM</given-names></name><name><surname>Anderson</surname><given-names>LJ</given-names></name><name><surname>Haynes</surname><given-names>LM</given-names></name><name><surname>Tripp</surname><given-names>RA</given-names></name><etal/></person-group>
<article-title>Respiratory syncytial virus activates innate immunity through toll-like receptor 2</article-title>. <source>J Virol</source> (<year>2009</year>) <volume>83</volume>(<issue>3</issue>):<fpage>1492</fpage>&#x02013;<lpage>500</lpage>.<pub-id pub-id-type="doi">10.1128/JVI.00671-08</pub-id><?supplied-pmid 19019963?><pub-id pub-id-type="pmid">19019963</pub-id></mixed-citation></ref><ref id="B101"><label>101</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alloatti</surname><given-names>A</given-names></name><name><surname>Kotsias</surname><given-names>F</given-names></name><name><surname>Pauwels</surname><given-names>AM</given-names></name><name><surname>Carpier</surname><given-names>JM</given-names></name><name><surname>Jouve</surname><given-names>M</given-names></name><name><surname>Timmerman</surname><given-names>E</given-names></name><etal/></person-group>
<article-title>Toll-like receptor 4 engagement on dendritic cells restrains phago-lysosome fusion and promotes cross-presentation of antigens</article-title>. <source>Immunity</source> (<year>2015</year>) <volume>43</volume>(<issue>6</issue>):<fpage>1087</fpage>&#x02013;<lpage>100</lpage>.<pub-id pub-id-type="doi">10.1016/j.immuni.2015.11.006</pub-id><?supplied-pmid 26682983?><pub-id pub-id-type="pmid">26682983</pub-id></mixed-citation></ref><ref id="B102"><label>102</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Johnson</surname><given-names>TR</given-names></name><name><surname>McLellan</surname><given-names>JS</given-names></name><name><surname>Graham</surname><given-names>BS</given-names></name></person-group>. <article-title>Respiratory syncytial virus glycoprotein G interacts with DC-SIGN and L-SIGN to activate ERK1 and ERK2</article-title>. <source>J Virol</source> (<year>2012</year>) <volume>86</volume>(<issue>3</issue>):<fpage>1339</fpage>&#x02013;<lpage>47</lpage>.<pub-id pub-id-type="doi">10.1128/JVI.06096-11</pub-id><?supplied-pmid 22090124?><pub-id pub-id-type="pmid">22090124</pub-id></mixed-citation></ref><ref id="B103"><label>103</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gomez</surname><given-names>RS</given-names></name><name><surname>Ramirez</surname><given-names>BA</given-names></name><name><surname>Cespedes</surname><given-names>PF</given-names></name><name><surname>Cautivo</surname><given-names>KM</given-names></name><name><surname>Riquelme</surname><given-names>SA</given-names></name><name><surname>Prado</surname><given-names>CE</given-names></name><etal/></person-group>
<article-title>Contribution of Fcgamma receptors to human respiratory syncytial virus pathogenesis and the impairment of T-cell activation by dendritic cells</article-title>. <source>Immunology</source> (<year>2016</year>) <volume>147</volume>(<issue>1</issue>):<fpage>55</fpage>&#x02013;<lpage>72</lpage>.<pub-id pub-id-type="doi">10.1111/imm.12541</pub-id><pub-id pub-id-type="pmid">26451966</pub-id></mixed-citation></ref><ref id="B104"><label>104</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cespedes</surname><given-names>PF</given-names></name><name><surname>Bueno</surname><given-names>SM</given-names></name><name><surname>Ramirez</surname><given-names>BA</given-names></name><name><surname>Gomez</surname><given-names>RS</given-names></name><name><surname>Riquelme</surname><given-names>SA</given-names></name><name><surname>Palavecino</surname><given-names>CE</given-names></name><etal/></person-group>
<article-title>Surface expression of the hRSV nucleoprotein impairs immunological synapse formation with T cells</article-title>. <source>Proc Natl Acad Sci U S A</source> (<year>2014</year>) <volume>111</volume>(<issue>31</issue>):<fpage>E3214</fpage>&#x02013;<lpage>23</lpage>.<pub-id pub-id-type="doi">10.1073/pnas.1400760111</pub-id><?supplied-pmid 25056968?><pub-id pub-id-type="pmid">25056968</pub-id></mixed-citation></ref><ref id="B105"><label>105</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>do Nascimento de Freitas</surname><given-names>D</given-names></name><name><surname>Gassen</surname><given-names>RB</given-names></name><name><surname>Fazolo</surname><given-names>T</given-names></name><name><surname>Souza</surname><given-names>APD</given-names></name></person-group>. <article-title>Rapamycin increases RSV RNA levels and survival of RSV-infected dendritic cell depending on T cell contact</article-title>. <source>Toxicol In Vitro</source> (<year>2016</year>) <volume>36</volume>:<fpage>114</fpage>&#x02013;<lpage>9</lpage>.<pub-id pub-id-type="doi">10.1016/j.tiv.2016.07.016</pub-id><?supplied-pmid 27466155?><pub-id pub-id-type="pmid">27466155</pub-id></mixed-citation></ref><ref id="B106"><label>106</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sung</surname><given-names>SS</given-names></name><name><surname>Fu</surname><given-names>SM</given-names></name><name><surname>Rose</surname><given-names>CE</given-names><suffix>Jr</suffix></name><name><surname>Gaskin</surname><given-names>F</given-names></name><name><surname>Ju</surname><given-names>ST</given-names></name><name><surname>Beaty</surname><given-names>SR</given-names></name></person-group>. <article-title>A major lung CD103 (alphaE)-beta7 integrin-positive epithelial dendritic cell population expressing Langerin and tight junction proteins</article-title>. <source>J Immunol</source> (<year>2006</year>) <volume>176</volume>(<issue>4</issue>):<fpage>2161</fpage>&#x02013;<lpage>72</lpage>.<pub-id pub-id-type="doi">10.4049/jimmunol.176.4.2161</pub-id><?supplied-pmid 16455972?><pub-id pub-id-type="pmid">16455972</pub-id></mixed-citation></ref><ref id="B107"><label>107</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ho</surname><given-names>AW</given-names></name><name><surname>Prabhu</surname><given-names>N</given-names></name><name><surname>Betts</surname><given-names>RJ</given-names></name><name><surname>Ge</surname><given-names>MQ</given-names></name><name><surname>Dai</surname><given-names>X</given-names></name><name><surname>Hutchinson</surname><given-names>PE</given-names></name><etal/></person-group>
<article-title>Lung CD103+ dendritic cells efficiently transport influenza virus to the lymph node and load viral antigen onto MHC class I for presentation to CD8 T cells</article-title>. <source>J Immunol</source> (<year>2011</year>) <volume>187</volume>(<issue>11</issue>):<fpage>6011</fpage>&#x02013;<lpage>21</lpage>.<pub-id pub-id-type="doi">10.4049/jimmunol.1100987</pub-id><?supplied-pmid 22043017?><pub-id pub-id-type="pmid">22043017</pub-id></mixed-citation></ref><ref id="B108"><label>108</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hildner</surname><given-names>K</given-names></name><name><surname>Edelson</surname><given-names>BT</given-names></name><name><surname>Purtha</surname><given-names>WE</given-names></name><name><surname>Diamond</surname><given-names>M</given-names></name><name><surname>Matsushita</surname><given-names>H</given-names></name><name><surname>Kohyama</surname><given-names>M</given-names></name><etal/></person-group>
<article-title>Batf3 deficiency reveals a critical role for CD8&#x003b1;+ dendritic cells in cytotoxic T cell immunity</article-title>. <source>Science</source> (<year>2008</year>) <volume>322</volume>(<issue>5904</issue>):<fpage>1097</fpage>&#x02013;<lpage>100</lpage>.<pub-id pub-id-type="doi">10.1126/science.1164206</pub-id><pub-id pub-id-type="pmid">19008445</pub-id></mixed-citation></ref><ref id="B109"><label>109</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Helft</surname><given-names>J</given-names></name><name><surname>Manicassamy</surname><given-names>B</given-names></name><name><surname>Guermonprez</surname><given-names>P</given-names></name><name><surname>Hashimoto</surname><given-names>D</given-names></name><name><surname>Silvin</surname><given-names>A</given-names></name><name><surname>Agudo</surname><given-names>J</given-names></name><etal/></person-group>
<article-title>Cross-presenting CD103+ dendritic cells are protected from influenza virus infection</article-title>. <source>J Clin Invest</source> (<year>2012</year>) <volume>122</volume>(<issue>11</issue>):<fpage>4037</fpage>&#x02013;<lpage>47</lpage>.<pub-id pub-id-type="doi">10.1172/JCI60659</pub-id><?supplied-pmid 23041628?><pub-id pub-id-type="pmid">23041628</pub-id></mixed-citation></ref><ref id="B110"><label>110</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ruckwardt</surname><given-names>TJ</given-names></name><name><surname>Malloy</surname><given-names>AM</given-names></name><name><surname>Morabito</surname><given-names>KM</given-names></name><name><surname>Graham</surname><given-names>BS</given-names></name></person-group>. <article-title>Quantitative and qualitative deficits in neonatal lung-migratory dendritic cells impact the generation of the CD8+ T cell response</article-title>. <source>PLoS Pathog</source> (<year>2014</year>) <volume>10</volume>(<issue>2</issue>):<fpage>e1003934</fpage>.<pub-id pub-id-type="doi">10.1371/journal.ppat.1003934</pub-id><?supplied-pmid 24550729?><pub-id pub-id-type="pmid">24550729</pub-id></mixed-citation></ref><ref id="B111"><label>111</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>P</given-names></name><name><surname>Hartert</surname><given-names>TV</given-names></name></person-group>
<article-title>Evidence for a causal relationship between respiratory syncytial virus infection and asthma</article-title>. <source>Expert Rev Anti Infect Ther</source> (<year>2011</year>) <volume>9</volume>(<issue>9</issue>):<fpage>731</fpage>&#x02013;<lpage>45</lpage>.<pub-id pub-id-type="doi">10.1586/eri.11.92</pub-id><pub-id pub-id-type="pmid">21905783</pub-id></mixed-citation></ref><ref id="B112"><label>112</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Knudson</surname><given-names>CJ</given-names></name><name><surname>Varga</surname><given-names>SM</given-names></name></person-group>
<article-title>The relationship between respiratory syncytial virus and asthma</article-title>. <source>Vet Pathol</source> (<year>2015</year>) <volume>52</volume>(<issue>1</issue>):<fpage>97</fpage>&#x02013;<lpage>106</lpage>.<pub-id pub-id-type="doi">10.1177/0300985814520639</pub-id><pub-id pub-id-type="pmid">24513802</pub-id></mixed-citation></ref><ref id="B113"><label>113</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Conejero</surname><given-names>L</given-names></name><name><surname>Khouili</surname><given-names>SC</given-names></name><name><surname>Martinez-Cano</surname><given-names>S</given-names></name><name><surname>Izquierdo</surname><given-names>HM</given-names></name><name><surname>Brandi</surname><given-names>P</given-names></name><name><surname>Sancho</surname><given-names>D</given-names></name></person-group>. <article-title>Lung CD103+ dendritic cells restrain allergic airway inflammation through IL-12 production</article-title>. <source>JCI Insight</source> (<year>2017</year>) <volume>2</volume>(<issue>10</issue>):<fpage>90420</fpage>.<pub-id pub-id-type="doi">10.1172/jci.insight.90420</pub-id><?supplied-pmid 28515363?><pub-id pub-id-type="pmid">28515363</pub-id></mixed-citation></ref><ref id="B114"><label>114</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lukens</surname><given-names>MV</given-names></name><name><surname>Kruijsen</surname><given-names>D</given-names></name><name><surname>Coenjaerts</surname><given-names>FE</given-names></name><name><surname>Kimpen</surname><given-names>JL</given-names></name><name><surname>van Bleek</surname><given-names>GM</given-names></name></person-group>. <article-title>Respiratory syncytial virus-induced activation and migration of respiratory dendritic cells and subsequent antigen presentation in the lung-draining lymph node</article-title>. <source>J Virol</source> (<year>2009</year>) <volume>83</volume>(<issue>14</issue>):<fpage>7235</fpage>&#x02013;<lpage>43</lpage>.<pub-id pub-id-type="doi">10.1128/JVI.00452-09</pub-id><?supplied-pmid 19420085?><pub-id pub-id-type="pmid">19420085</pub-id></mixed-citation></ref><ref id="B115"><label>115</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Persson</surname><given-names>EK</given-names></name><name><surname>Uronen-Hansson</surname><given-names>H</given-names></name><name><surname>Semmrich</surname><given-names>M</given-names></name><name><surname>Rivollier</surname><given-names>A</given-names></name><name><surname>Hagerbrand</surname><given-names>K</given-names></name><name><surname>Marsal</surname><given-names>J</given-names></name><etal/></person-group>
<article-title>IRF4 transcription-factor-dependent CD103(+)CD11b(+) dendritic cells drive mucosal T helper 17 cell differentiation</article-title>. <source>Immunity</source> (<year>2013</year>) <volume>38</volume>(<issue>5</issue>):<fpage>958</fpage>&#x02013;<lpage>69</lpage>.<pub-id pub-id-type="doi">10.1016/j.immuni.2013.03.009</pub-id><?supplied-pmid 23664832?><pub-id pub-id-type="pmid">23664832</pub-id></mixed-citation></ref><ref id="B116"><label>116</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Plantinga</surname><given-names>M</given-names></name><name><surname>Guilliams</surname><given-names>M</given-names></name><name><surname>Vanheerswynghels</surname><given-names>M</given-names></name><name><surname>Deswarte</surname><given-names>K</given-names></name><name><surname>Branco-Madeira</surname><given-names>F</given-names></name><name><surname>Toussaint</surname><given-names>W</given-names></name><etal/></person-group>
<article-title>Conventional and monocyte-derived CD11b(+) dendritic cells initiate and maintain T helper 2 cell-mediated immunity to house dust mite allergen</article-title>. <source>Immunity</source> (<year>2013</year>) <volume>38</volume>(<issue>2</issue>):<fpage>322</fpage>&#x02013;<lpage>35</lpage>.<pub-id pub-id-type="doi">10.1016/j.immuni.2012.10.016</pub-id><?supplied-pmid 23352232?><pub-id pub-id-type="pmid">23352232</pub-id></mixed-citation></ref><ref id="B117"><label>117</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kallal</surname><given-names>LE</given-names></name><name><surname>Schaller</surname><given-names>MA</given-names></name><name><surname>Lindell</surname><given-names>DM</given-names></name><name><surname>Lira</surname><given-names>SA</given-names></name><name><surname>Lukacs</surname><given-names>NW</given-names></name></person-group>. <article-title>CCL20/CCR6 blockade enhances immunity to RSV by impairing recruitment of DC</article-title>. <source>Eur J Immunol</source> (<year>2010</year>) <volume>40</volume>(<issue>4</issue>):<fpage>1042</fpage>&#x02013;<lpage>52</lpage>.<pub-id pub-id-type="doi">10.1002/eji.200939778</pub-id><?supplied-pmid 20101616?><pub-id pub-id-type="pmid">20101616</pub-id></mixed-citation></ref><ref id="B118"><label>118</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McDermott</surname><given-names>DS</given-names></name><name><surname>Weiss</surname><given-names>KA</given-names></name><name><surname>Knudson</surname><given-names>CJ</given-names></name><name><surname>Varga</surname><given-names>SM</given-names></name></person-group>. <article-title>Central role of dendritic cells in shaping the adaptive immune response during respiratory syncytial virus infection</article-title>. <source>Future Virol</source> (<year>2011</year>) <volume>6</volume>(<issue>8</issue>):<fpage>963</fpage>&#x02013;<lpage>73</lpage>.<pub-id pub-id-type="doi">10.2217/fvl.11.62</pub-id><?supplied-pmid 21887154?><pub-id pub-id-type="pmid">21887154</pub-id></mixed-citation></ref><ref id="B119"><label>119</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shrestha</surname><given-names>B</given-names></name><name><surname>You</surname><given-names>D</given-names></name><name><surname>Saravia</surname><given-names>J</given-names></name><name><surname>Siefker</surname><given-names>DT</given-names></name><name><surname>Jaligama</surname><given-names>S</given-names></name><name><surname>Lee</surname><given-names>GI</given-names></name><etal/></person-group>
<article-title>IL-4Ralpha on dendritic cells in neonates and Th2 immunopathology in respiratory syncytial virus infection</article-title>. <source>J Leukoc Biol</source> (<year>2017</year>) <volume>102</volume>(<issue>1</issue>):<fpage>153</fpage>&#x02013;<lpage>61</lpage>.<pub-id pub-id-type="doi">10.1189/jlb.4A1216-536R</pub-id><pub-id pub-id-type="pmid">28389622</pub-id></mixed-citation></ref><ref id="B120"><label>120</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hornung</surname><given-names>V</given-names></name><name><surname>Schlender</surname><given-names>J</given-names></name><name><surname>Guenthner-Biller</surname><given-names>M</given-names></name><name><surname>Rothenfusser</surname><given-names>S</given-names></name><name><surname>Endres</surname><given-names>S</given-names></name><name><surname>Conzelmann</surname><given-names>KK</given-names></name><etal/></person-group>
<article-title>Replication-dependent potent IFN-alpha induction in human plasmacytoid dendritic cells by a single-stranded RNA virus</article-title>. <source>J Immunol</source> (<year>2004</year>) <volume>173</volume>(<issue>10</issue>):<fpage>5935</fpage>&#x02013;<lpage>43</lpage>.<pub-id pub-id-type="doi">10.4049/jimmunol.173.10.5935</pub-id><?supplied-pmid 15528327?><pub-id pub-id-type="pmid">15528327</pub-id></mixed-citation></ref><ref id="B121"><label>121</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Smit</surname><given-names>JJ</given-names></name><name><surname>Lindell</surname><given-names>DM</given-names></name><name><surname>Boon</surname><given-names>L</given-names></name><name><surname>Kool</surname><given-names>M</given-names></name><name><surname>Lambrecht</surname><given-names>BN</given-names></name><name><surname>Lukacs</surname><given-names>NW</given-names></name></person-group>. <article-title>The balance between plasmacytoid DC versus conventional DC determines pulmonary immunity to virus infections</article-title>. <source>PLoS One</source> (<year>2008</year>) <volume>3</volume>(<issue>3</issue>):<fpage>e1720</fpage>.<pub-id pub-id-type="doi">10.1371/journal.pone.0001720</pub-id><?supplied-pmid 18320041?><pub-id pub-id-type="pmid">18320041</pub-id></mixed-citation></ref><ref id="B122"><label>122</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>H</given-names></name><name><surname>Peters</surname><given-names>N</given-names></name><name><surname>Schwarze</surname><given-names>J</given-names></name></person-group>. <article-title>Plasmacytoid dendritic cells limit viral replication, pulmonary inflammation, and airway hyperresponsiveness in respiratory syncytial virus infection</article-title>. <source>J Immunol</source> (<year>2006</year>) <volume>177</volume>(<issue>9</issue>):<fpage>6263</fpage>&#x02013;<lpage>70</lpage>.<pub-id pub-id-type="doi">10.4049/jimmunol.177.9.6263</pub-id><?supplied-pmid 17056556?><pub-id pub-id-type="pmid">17056556</pub-id></mixed-citation></ref><ref id="B123"><label>123</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Smit</surname><given-names>JJ</given-names></name><name><surname>Rudd</surname><given-names>BD</given-names></name><name><surname>Lukacs</surname><given-names>NW</given-names></name></person-group>. <article-title>Plasmacytoid dendritic cells inhibit pulmonary immunopathology and promote clearance of respiratory syncytial virus</article-title>. <source>J Exp Med</source> (<year>2006</year>) <volume>203</volume>(<issue>5</issue>):<fpage>1153</fpage>&#x02013;<lpage>9</lpage>.<pub-id pub-id-type="doi">10.1084/jem.20052359</pub-id><?supplied-pmid 16682497?><pub-id pub-id-type="pmid">16682497</pub-id></mixed-citation></ref><ref id="B124"><label>124</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kerrin</surname><given-names>A</given-names></name><name><surname>Fitch</surname><given-names>P</given-names></name><name><surname>Errington</surname><given-names>C</given-names></name><name><surname>Kerr</surname><given-names>D</given-names></name><name><surname>Waxman</surname><given-names>L</given-names></name><name><surname>Riding</surname><given-names>K</given-names></name><etal/></person-group>
<article-title>Differential lower airway dendritic cell patterns may reveal distinct endotypes of RSV bronchiolitis</article-title>. <source>Thorax</source> (<year>2017</year>) <volume>72</volume>(<issue>7</issue>):<fpage>620</fpage>&#x02013;<lpage>7</lpage>.<pub-id pub-id-type="doi">10.1136/thoraxjnl-2015-207358</pub-id><?supplied-pmid 27531529?><pub-id pub-id-type="pmid">27531529</pub-id></mixed-citation></ref><ref id="B125"><label>125</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lombardi</surname><given-names>V</given-names></name><name><surname>Speak</surname><given-names>AO</given-names></name><name><surname>Kerzerho</surname><given-names>J</given-names></name><name><surname>Szely</surname><given-names>N</given-names></name><name><surname>Akbari</surname><given-names>O</given-names></name></person-group>
<article-title>CD8alpha(+)beta(-) and CD8alpha(+)beta(+) plasmacytoid dendritic cells induce Foxp3(+) regulatory T cells and prevent the induction of airway hyper-reactivity</article-title>. <source>Mucosal Immunol</source> (<year>2012</year>) <volume>5</volume>(<issue>4</issue>):<fpage>432</fpage>&#x02013;<lpage>43</lpage>.<pub-id pub-id-type="doi">10.1038/mi.2012.20</pub-id><pub-id pub-id-type="pmid">22472775</pub-id></mixed-citation></ref><ref id="B126"><label>126</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kimpen</surname><given-names>JL</given-names></name><name><surname>Garofalo</surname><given-names>R</given-names></name><name><surname>Welliver</surname><given-names>RC</given-names></name><name><surname>Fujihara</surname><given-names>K</given-names></name><name><surname>Ogra</surname><given-names>PL</given-names></name></person-group>. <article-title>An ultrastructural study of the interaction of human eosinophils with respiratory syncytial virus</article-title>. <source>Pediatr Allergy Immunol</source> (<year>1996</year>) <volume>7</volume>(<issue>1</issue>):<fpage>48</fpage>&#x02013;<lpage>53</lpage>.<pub-id pub-id-type="doi">10.1111/j.1399-3038.1996.tb00105.x</pub-id><?supplied-pmid 8792384?><pub-id pub-id-type="pmid">8792384</pub-id></mixed-citation></ref></ref-list></back></article>